<SEC-DOCUMENT>0001213900-21-064831.txt : 20211213
<SEC-HEADER>0001213900-21-064831.hdr.sgml : 20211213
<ACCEPTANCE-DATETIME>20211213061351
ACCESSION NUMBER:		0001213900-21-064831
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20211208
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211213
DATE AS OF CHANGE:		20211213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Stran & Company, Inc.
		CENTRAL INDEX KEY:			0001872525
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-ADVERTISING AGENCIES [7311]
		IRS NUMBER:				043297200
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41038
		FILM NUMBER:		211486902

	BUSINESS ADDRESS:	
		STREET 1:		2 HERITAGE DRIVE
		STREET 2:		SUITE 600
		CITY:			QUINCY
		STATE:			MA
		ZIP:			02171
		BUSINESS PHONE:		8008333309

	MAIL ADDRESS:	
		STREET 1:		2 HERITAGE DRIVE
		STREET 2:		SUITE 600
		CITY:			QUINCY
		STATE:			MA
		ZIP:			02171
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea152147-8k_stranandcom.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:STRN="http://stran.com/20211208">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_STRN_stran.com_20211208 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20211208_20211208 -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DEntityCentralIndexKey_0001872525 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityCentralIndexKey">0001872525</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="strn-20211208.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-12-08to2021-12-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001872525</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-08</xbrli:startDate>
        <xbrli:endDate>2021-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-082021-12-08_custom_CommonStockParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001872525</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">STRN:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-08</xbrli:startDate>
        <xbrli:endDate>2021-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-12-082021-12-08_custom_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001872525</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">STRN:WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-12-08</xbrli:startDate>
        <xbrli:endDate>2021-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>FORM
<span id="xdx_908_edei--DocumentType_c20211208__20211208_z14zz3VXOHj1"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Pursuant
to Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">Date
of Report (Date of earliest event reported): <span id="xdx_90D_edei--DocumentPeriodEndDate_c20211208__20211208_z0zD0FaEv2if"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 8, 2021</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityRegistrantName_c20211208__20211208_zkyDgSa1XWtc"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityRegistrantName">STRAN
    &amp; COMPANY, INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Exact
    name of registrant as specified in its charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90F_edei--EntityIncorporationStateCountryCode_c20211208__20211208_zJiSI586UXy3"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityFileNumber_c20211208__20211208_zNMZQFekT1P3"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityFileNumber">001-41038</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_909_edei--EntityTaxIdentificationNumber_c20211208__20211208_zBUYvsPO59dc"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityTaxIdentificationNumber">04-3297200</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(State or other jurisdiction<br />
    of incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission File Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer <br />
    Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20211208__20211208_zudEaGEuQ0O2"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityAddressAddressLine1">2
    Heritage Drive</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20211208__20211208_zXlmj5fAYmd9"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityAddressAddressLine2">Suite 600</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressCityOrTown_c20211208__20211208_zgvcT9PRewA"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityAddressCityOrTown">Quincy</ix:nonNumeric></span>, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20211208__20211208_zDYiAJl5h6T8"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityAddressStateOrProvince">MA</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_906_edei--EntityAddressPostalZipCode_c20211208__20211208_zlXl5qUmZiLd"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:EntityAddressPostalZipCode">02171</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Address of principal executive
    offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_901_edei--CityAreaCode_c20211208__20211208_zBbKX61nmDd6"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:CityAreaCode">800</ix:nonNumeric></span>-<span id="xdx_90A_edei--LocalPhoneNumber_c20211208__20211208_ztnKP3xzMEb1"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" name="dei:LocalPhoneNumber">833-3309</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Registrant&#8217;s telephone
    number, including area code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Former
    name or former address, if changed since last report)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90B_edei--WrittenCommunications_c20211208__20211208_zAhWi2qLroyd"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_906_edei--SolicitingMaterial_c20211208__20211208_zHbm7Dc9F6x9"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20211208__20211208_zeX0d3SXL0ii"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR&#160;240.14d-2(b))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20211208__20211208_zv83er7y5Fye"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></td>
</tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading Symbol(s)</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 32%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--Security12bTitle_c20211208__20211208__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zoRHY5sX77rf"><ix:nonNumeric contextRef="From2021-12-082021-12-08_custom_CommonStockParValue0.0001PerShareMember" name="dei:Security12bTitle">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_edei--TradingSymbol_c20211208__20211208__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zWvp5e6zRhA7"><ix:nonNumeric contextRef="From2021-12-082021-12-08_custom_CommonStockParValue0.0001PerShareMember" name="dei:TradingSymbol">STRN</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The <span id="xdx_904_edei--SecurityExchangeName_c20211208__20211208__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.0001PerShareMember_zB5wlN6BoQR6"><ix:nonNumeric contextRef="From2021-12-082021-12-08_custom_CommonStockParValue0.0001PerShareMember" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--Security12bTitle_c20211208__20211208__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member_zOUW9UCF94u8"><ix:nonNumeric contextRef="From2021-12-082021-12-08_custom_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" name="dei:Security12bTitle">Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $5.1875</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_c20211208__20211208__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member_zZu3iGgE1W9l"><ix:nonNumeric contextRef="From2021-12-082021-12-08_custom_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" name="dei:TradingSymbol">STRNW</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">The <span id="xdx_900_edei--SecurityExchangeName_c20211208__20211208__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member_zZN1RMiMfNwk"><ix:nonNumeric contextRef="From2021-12-082021-12-08_custom_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2
of the Securities Exchange Act of 1934. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">Emerging
Growth Company <span id="xdx_909_edei--EntityEmergingGrowthCompany_c20211208__20211208_zVRE0t3uDdje"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt:booleantrue" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_907_edei--EntityExTransitionPeriod_c20211208__20211208_zc3j7L7eT0r6"><ix:nonNumeric contextRef="From2021-12-08to2021-12-08" format="ixt:booleanfalse" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0%"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
                          1.01</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Entry
                                            into a Material Definitive Agreement.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
December 10, 2021, Stran &amp; Company, Inc. (the &#8220;Company&#8221;) completed a private placement with several investors, wherein
a total of 4,371,926 shares (the &#8220;Shares&#8221;) of the Company&#8217;s Common Stock, par value $0.0001 per share (the &#8220;Common
Stock&#8221;) were issued at a purchase price of $4.97 per share, with each investor also receiving a warrant to purchase up to a number
of shares of Common Stock equal to 125% of the number of shares of Common Stock purchased by such investor in the Offering, at an exercise
price of $4.97 per share (the &#8220;Purchaser Warrants&#8221;), for a total purchase price of approximately $21.7 million (the &#8220;Offering&#8221;).
The Purchaser Warrants are immediately exercisable on the date of issuance, expire five years from the date of issuance and have certain
downward pricing adjustment mechanisms, including with respect to any subsequent equity sale that is deemed a dilutive issuance, in which
case the warrants will be subject to a floor price of $4.80 per share before shareholder approval is obtained, and after shareholder
approval is obtained, such floor price will be reduced to $1.00 per share, as set forth in the Purchaser Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 47.05pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The Offering raised net
cash proceeds of approximately $19.8 million (after deducting the placement agent fee and expenses of the Offering). The Company intends
to use the net cash proceeds from the Offering for acquisitions and partnerships, investments in technology and expanding corporate infrastructure,
expansion of its sales team and marketing efforts and for general working capital and administrative purposes.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 47.05pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Company engaged EF Hutton, division of Benchmark Investments, LLC (&#8220;EF Hutton&#8221;) as the Company&#8217;s placement agent for
the Offering pursuant to a Placement Agency Agreement (the &#8220;PAA&#8221;) dated as of December 8, 2021. Pursuant to the PAA, the
Company agreed to pay EF Hutton a cash placement fee equal to 8.0% of the gross proceeds of the Offering, an additional cash fee equal
to 0.5% of the gross proceeds raised by the Company in the offering for non-accountable expenses, and also agreed to reimburse EF Hutton
up to $100,000 for accountable expenses. In addition, EF Hutton&#8217;s designees received warrants to purchase an aggregate of 131,158
shares of Common Stock, which is equal to 3.0% of the total number of shares issued in the Offering, at an exercise price of $4.97 per
share (the &#8220;Representative Warrants&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 47.05pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">In
connection with the Offering, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with investors
containing customary representations and warranties. The Company and investors also entered into a Registration Rights Agreement (the
&#8220;Registration Rights Agreement&#8221;), pursuant to which the Company will be required to file a resale registration statement
(the &#8220;Registration Statement&#8221;) with the Securities and Exchange Commission (the &#8220;SEC&#8221;) to register for resale
the Shares and the shares of Common Stock issuable upon exercise of the Purchaser Warrants and Representative Warrants, promptly following
the Closing Date but in no event later than 15 calendar days after the effective date of the Registration Rights Agreement, and to have
such Registration Statement declared effective by the Effectiveness Date (as defined in the Registration Rights Agreement). The Company
will be obligated to pay certain liquidated damages to the investors if the Company fails to file the Registration Statement when required,
fails to file or cause the Registration Statement to be declared effective by the SEC when required, or fails to maintain the effectiveness
of the Registration Statement pursuant to the terms of the Registration Rights Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 47.05pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
representations, warranties and covenants contained in the Purchase Agreement and the Registration Rights Agreement were made solely
for the benefit of the parties to the Purchase Agreement and may be subject to limitations agreed upon by the contracting parties. In
addition, such representations, warranties and covenants (i)&#160;are intended as a way of allocating the risk between the parties to
the Purchase Agreement and not as statements of fact, and (ii)&#160;may apply standards of materiality in a way that is different from
what may be viewed as material by stockholders of, or other investors in, the Company. Accordingly, forms of the Purchase Agreement and
the Registration Rights Agreement are filed with this report only to provide investors with information regarding the terms of transaction,
and not to provide investors with any other factual information regarding the Company. Stockholders should not rely on the representations,
warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company. Moreover,
information concerning the subject matter of the representations and warranties may change after the date of the Purchase Agreement and
the Registration Rights Agreement, which subsequent information may or may not be fully reflected in public disclosures.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
Offering was exempt from the registration requirements of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) pursuant
to the exemption for transactions by an issuer not involving any public offering under Section&#160;4(a)(2) of the Securities Act and
Rule 506 of Regulation D of the Securities Act and in reliance on similar exemptions under applicable state laws. Each of the Purchasers
represented that it is an accredited investor within the meaning of Rule 501(a) of Regulation D, and was acquiring the securities for
investment only and not with a view towards, or for resale in connection with, the public sale or distribution thereof. The securities
were offered without any general solicitation by the Company or its representatives.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 47.05pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 47.05pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"></span></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 47.05pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
foregoing description of each of the Purchase Agreement, PAA, Registration Rights Agreement, form of Purchaser Warrant and form of Representative
Warrant is qualified in its entirety by reference to the forms of such documents which are filed hereto as Exhibits 10.1, 10.2, 10.3,
10.4, and 10.5 respectively.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.65in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>Item
                           3.02</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>Unregistered
Sales of Equity Securities</b></span><b><span style="font: 10pt Times New Roman, Times, Serif">.</span></b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">The
matters described in Section 1.01 of this Current Report on Form 8-K are incorporated herein by reference. In connection with the issuance
of the securities described in Item 1.01, the Company relied upon the exemption from registration provided by Section 4(a)(2) of the
Securities Act of 1933, as amended, and Regulation D promulgated thereunder for transactions not involving a public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 45pt; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0%"></td><td style="width: 0.65in; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
                           8.01</b></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Other
Events.</b></span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">On
December 8, 2021, the Company issued a press release announcing the pricing of the Offering. On December 10, 2021, the Company issued
a press release announcing the closing of the Offering. <span style="background-color: white">The press releases, which are furnished
in this report as Exhibits 99.1 and 99.2, shall not be deemed to be &#8220;filed&#8221; for the purposes of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liabilities of that section.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0%"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.65in"><span style="font: 10pt Times New Roman, Times, Serif"><b>Item
                          9.01</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Financial
                                            Statements and Exhibits.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 9%; padding-right: 0; padding-left: 0"><b>Exhibit No.</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 90%; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Description
    of Exhibit</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><a href="ea152147ex10-1_stranandco.htm"><span style="font: 10pt Times New Roman, Times, Serif">Form of Securities Purchase Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><a href="ea152147ex10-2_stranandco.htm"><span style="font: 10pt Times New Roman, Times, Serif">Placement Agency Agreement dated December 8, 2021</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><a href="ea152147ex10-3_stranandco.htm"><span style="font: 10pt Times New Roman, Times, Serif">Form of Registration Rights Agreement</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><a href="ea152147ex10-4_stranandco.htm"><span style="font: 10pt Times New Roman, Times, Serif">Form of Purchaser Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><a href="ea152147ex10-5_stranandco.htm"><span style="font: 10pt Times New Roman, Times, Serif">Form of Representative Warrant</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><a href="ea152147ex99-1_stranandco.htm"><span style="font: 10pt Times New Roman, Times, Serif">Press Release dated December 8, 2021</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><a href="ea152147ex99-2_stranandco.htm"><span style="font: 10pt Times New Roman, Times, Serif">Press Release dated December 10, 2021</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 0; padding-left: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Date: December 13, 2021</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">STRAN &amp; COMPANY, INC.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">/s/ Andrew Shape</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font: 10pt Times New Roman, Times, Serif">Name:&#160; </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font: 10pt Times New Roman, Times, Serif">Andrew Shape</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Title: </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">3</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kU1uwjAQhU/AHUYRywjsCNSKHY0AVYUSQUW7NWFSLBJPNA5/R+ot6zhEsGitSLY17833xgmCMJjRVOfI8PWymsMHFmWuKoQVZshoUnSK+PVtBG5f4be2FStT+WtrjMl50HmGPSlSV/DSk7a4G4GM+lL2I+kOo8EAxougU9djMpneoam0ykGZHSRMJWusFF+bDh/qQoaKq0dtkK0m49r1RFP+gUjICN7ppM7EBwvzeRx0Qr86wYzpWNaYo62ogEmOhWPZxnr/fJTUa0afiuvJ7ESl+9t5ckFOtVXbHKfES4PrvWJcZm7ggsy6ovQwbkWYsE5dzb3B89NwgcUW2TWXInI5x7fQLSMEdBQ4N1fAOwcyYiCDYGsUUAYNDDwNVOUeq9UjlDWzFnUb7B9jPWRNFG9UfkTRE0LIBNmP80/UR2wIpWI41V7oNm4o3Y/3GVvmLwuxtIA= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea152147ex10-1_stranandco.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: none; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-transform: uppercase; text-align: center"><B>SECURITIES PURCHASE
AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of December 8, 2021, between Stran &amp; Company, Inc., a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below), and Rule 506 promulgated
thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase
from the Company, securities of the Company as more fully described in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which
are hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ARTICLE I.<BR>
DEFINITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.1 <U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo;&nbsp; or any other similar orders or restrictions or the closure of any physical branch locations
at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York generally are open for use by customers on such day</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.0001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
Counsel</U>&rdquo; means Bevilacqua PLLC, U.S., with offices located at 1050 Connecticut Avenue, NW, Suite 500, Washington, DC 20036.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date hereof,
unless otherwise instructed as to an earlier time by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement has been declared effective by the Commission,
(b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement
for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions,
(c) following the one year anniversary of the Closing Date provided that a holder of Shares or Warrant Shares is not an Affiliate of the
Company, or (d) all of the Shares and Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1) of the
Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written unqualified
opinion that resales may then be made by such holders of the Shares and Warrant Shares pursuant to such exemption which opinion shall
be in form and substance reasonably acceptable to such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow
Agent</U>&rdquo; means Salem Five Cents Savings Bank, with offices at 210 Essex Street, Salem, MA 01970.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the escrow agreement entered into prior to the date hereof, by and among the Company, the Escrow Agent and
the Placement Agent pursuant to which the Purchasers shall deposit Subscription Amounts with the Escrow Agent to be applied to the transactions
contemplated hereunder</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock or options to employees, officers or directors of the Company or
consultants of the Company who are not also officers or directors pursuant to any stock or option plan duly adopted for such purpose,
by a majority of the non-employee members of the Board of Directors or a majority of the members of a committee of non-employee directors
established for such purpose for services rendered to the Company; provided, that with respect to issuances to consultants who are not
also officers or directors, such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration
rights that require or permit the filing of any registration statement in connection therewith during the prohibition period in Section
4.11(a) herein, (b) warrants to the Placement Agent in connection with the transactions pursuant to this Agreement and any securities
upon exercise of such warrants to the Placement Agent, securities upon the exercise or exchange of or conversion of any Securities issued
hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on
the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number
of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection
with stock splits or combinations) or to extend the term of such securities, (c) securities issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted
securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement
in connection therewith during the prohibition period in Section 4.11(a) herein, and provided that any such issuance shall only be to
a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset
in a business synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment
of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of raising capital
or to an entity whose primary business is investing in securities, (d) shares of Common Stock, options or convertible securities issued
to banks, equipment lessors or other financial institutions, or to real property lessors, pursuant to a debt financing, equipment leasing
or real property leasing transaction approved by a majority of the disinterested directors of the Company, provided that such securities
are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that require or permit the
filing of any registration statement in connection therewith during the prohibition period in Section 4.11(a) herein, (e) shares of Common
Stock, options or convertible securities issued to in connection with the provision of goods pursuant to transactions approved by a majority
of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined
in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection therewith
during the prohibition period in Section 4.11(a) herein and (f) shares of Common Stock, options or convertible securities issued in connection
with sponsored research, collaboration, technology license, development, marketing or other similar agreements or strategic partnerships
approved a majority of the disinterested directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo;
(as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration statement in connection
therewith during the prohibition period in Section 4.11(a) herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">. &ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $4.97 for one share of Common Stock plus 1.25 Warrants, subject to adjustment for reverse and forward
stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means EF Hutton.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">&ldquo;<U>Placement
Agent Counsel</U>&rdquo; means Robinson &amp; Cole LLP, with offices located at 1055 Washington Boulevard, Stamford, CT 06901.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit B</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Shares and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shareholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the shareholders of the Company to render inapplicable the provisions of clause (i) of the definition of &ldquo;Floor
Price&rdquo; (as defined in the Warrants).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in
United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U> and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange, (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Registration Rights Agreement, all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means VStock Transfer, LLC, the current transfer agent of the Company, with a mailing address of 18 Lafayette Place,
Woodmere, NY 11598 and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.11(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted
average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock
is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common
Stock so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof,
which Warrants shall be immediately exercisable and shall have a term of exercise equal to five (5) years, in the form of <U>Exhibit C</U>
attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B></B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE II.</B><BR>
<B>PURCHASE AND SALE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.1 <U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
at a price of $4.97 per share (which shall include 1.25 Warrants for each share purchased), up to an aggregate of $21,728,472 of Shares
and Warrants. Each Purchaser shall deliver to the Escrow Agent, via wire transfer or a certified check, immediately available funds equal
to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser, and the Company shall
deliver to each Purchaser its respective Shares and a Warrant, as determined pursuant to Section 2.2(a), and the Company and each Purchaser
shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set
forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Placement Agent Counsel or such other location as the parties
shall mutually agree.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.2 <U>Deliveries
at Closing</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) a
legal opinion of Company Counsel, in form and substance reasonably acceptable to the Placement Agent and each Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) a
copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered
in the name of such Purchaser, or, at the election of such Purchaser, evidence of the issuance of such Purchaser&rsquo;s Shares hereunder
as held in DRS book-entry form by the Transfer Agent and registered in the name of such Purchaser, which evidence shall be reasonably
satisfactory to such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) a
Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 125% of such Purchaser&rsquo;s
Shares, with an exercise price equal to $4.97, subject to adjustment therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) the
Company shall have provided each Purchaser with the Company&rsquo;s and the Escrow Agent&rsquo;s wire instructions, in each case on Company
letterhead and executed by the Chief Executive Officer or Chief Financial Officer; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi) the
Registration Rights Agreement duly executed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Escrow Agent, as applicable, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) to
the Company, this Agreement duly executed by such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) to
the Escrow Agent or the Company, such Purchaser&rsquo;s Subscription Amount payable with respect to the Securities being acquired at the
Closing by wire transfer to the account specified in writing by the Company the Escrow Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) to
the Company, the Registration Rights Agreement duly executed by such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">2.3 <U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific
date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii) all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv) there
shall have been no Material Adverse Effect with respect to the Company since the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v) the
Company shall have received the clearance of the Nasdaq Capital Market with respect to the execution and delivery of the Transaction Documents
and the consummation of the transactions contemplated by the Transaction Documents; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi) from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of such Purchaser,
makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE III.<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.1 <U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Subsidiaries</U>.
All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them in
the Transaction Documents shall be disregarded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse
effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company&rsquo;s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute
the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as limited by
general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive
relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing
a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property
or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in
a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority
to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any property
or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not
have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) the filing with the Commission pursuant to the Registration Rights Agreement, (iii) the notice
and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Shares and
Warrant Shares for trading thereon in the time and manner required thereby, and (iv) the filing of Form D with the Commission and such
filings as are required to be made under applicable state securities laws and (v) Shareholder Approval (collectively, the &ldquo;<U>Required
Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Issuance
of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than
restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the terms of the
Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other
than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock
the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
The Company has not issued any capital stock since its most recently filed periodic report under the Exchange Act, other than pursuant
to the exercise of employee stock options under the Company&rsquo;s stock option plans, the issuance of shares of Common Stock to employees
pursuant to the Company&rsquo;s employee stock purchase plans and pursuant to the conversion and/or exercise of Common Stock Equivalents
outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal,
preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents.
Except as set forth on <U>Schedule 3.1(g)</U> or as a result of the purchase and sale of the Securities, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations
convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares of Common
Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company or any Subsidiary
is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The
issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or other securities
to any Person (other than the Purchasers). There are no outstanding securities or instruments of the Company or any Subsidiary with any
provision that adjusts the exercise, conversion, exchange or reset price of such security or instrument upon an issuance of securities
by the Company or any Subsidiary. There are no outstanding securities or instruments of the Company or any Subsidiary that contain any
redemption or similar provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any
Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation
rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock
of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and
state securities laws, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe
for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect
to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the
Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h) <U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
&ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC
Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects
with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer
subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in the SEC Reports comply in all material
respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at
the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles
applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly
present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing Company stock option plans. The Company does not have pending before the Commission any request for confidential treatment
of information. Except for the issuance of the Securities contemplated by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no
event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to occur or exist with
respect to the Company or its Subsidiaries or their respective businesses, prospects, properties, operations, assets or financial condition
that would be required to be disclosed by the Company under applicable securities laws at the time this representation is made or deemed
made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) <U>Litigation</U>.
Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission
has not issued any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary
under the Exchange Act or the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) <U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) <U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)  <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n) <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal,
state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports, except
where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (&ldquo;<U>Material
Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification
of any Material Permit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o) <U>Title
to Assets</U>. Except where the failure to possess could not reasonably be expected to result in a Material Adverse Effect, the Company
and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good and marketable title in
all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each case free and clear
of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere with the use
made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal, state or
other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which is neither delinquent
nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by them under
valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance, except where the failure to possess
could not reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(p) <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). None of, and neither
the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired,
terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement.
Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC
Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the
rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the
Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(q) <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(r) <U>Transactions
with Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any
transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(s) <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting
controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management&rsquo;s general
or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s general or specific
authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls
and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The
Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company and the
Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation
Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying
officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since
the Evaluation Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange
Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control
over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(t) <U>Certain
Fees</U>. No brokerage or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial
advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents, other than payment of commissions, fees and expenses payable to the Placement Agent. The Purchasers shall
have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(u) <U>Private
Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.
The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v) <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(w) <U>Registration
Rights</U>. Other than each of the Purchasers and EF Hutton, no Person has any right to cause the Company or any Subsidiary to effect
the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(x) <U>Listing
and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
The Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is
or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such
Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance
with all such listing and maintenance requirements. The Common Stock is currently eligible for electronic transfer through the Depository
Trust Company or another established clearing corporation and the Company is current in payment of the fees to the Depository Trust Company
(or such other established clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(y) <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(z) <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers
will rely on the foregoing representation in effecting transactions in securities of the Company. All of the disclosure furnished by or
on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective businesses and the transactions
contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct in all material respects and does not contain
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in
the light of the circumstances under which they were made, not misleading. The press releases disseminated by the Company during the twelve
months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under
which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(aa) <U>No Integrated
Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company,
nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security
or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under
the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the
Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(bb) <U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company
of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount
that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent
liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as
now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the
business conducted by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current
cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into
account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts
are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances
which lead it to believe that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction
within one year from the Closing Date. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured
Indebtedness of the Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement,
&ldquo;<U>Indebtedness</U>&rdquo; means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade
accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect
of indebtedness of others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the
notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary
course of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in
accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(cc) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and
franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other
governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations
and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(dd) <U>No General
Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any
form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain
other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ee) <U>Foreign
Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other
person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts,
entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign
or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii)
failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the
Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ff) <U>Accountants</U>.
The Company&rsquo;s accounting firm is set forth on <U>Schedule 3.1(ff)</U> of the Disclosure Schedules. To the knowledge and belief of
the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its
opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ending December
31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(gg) <U>No Disagreements
with Accountants and Lawyers.</U> There are no disagreements of any kind presently existing, or reasonably anticipated by the Company
to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current
with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations
under any of the Transaction Documents.  </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(hh)  <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) <FONT STYLE="text-underline-style: double"><U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. </FONT>Anything in this Agreement or elsewhere herein to the contrary
notwithstanding (except for Sections 3.2(g) and 4.14 hereof), it is understood and acknowledged by the Company that: (i) none of the
Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or
short, securities of the Company, or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the
Securities for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including,
without limitation, Short Sales or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future private
placement transactions, may negatively impact the market price of the Company&rsquo;s publicly-traded securities, (iii) any
Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions to which any such Purchaser is a party, directly or
indirectly, presently may have a &ldquo;short&rdquo; position in the Common Stock and (iv) each Purchaser shall not be deemed to
have any affiliation with or control over any arm&rsquo;s length counter-party in any &ldquo;derivative&rdquo; transaction. The
Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times
during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the
Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce
the value of the existing stockholders' equity interests in the Company at and after the time that the hedging activities are being
conducted.&nbsp; The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the
Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(jj) <U>Regulation
M Compliance.</U>&nbsp; The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company&rsquo;s placement agent in connection
with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(kk) <U>Stock
Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan was granted (i) in accordance with
the terms of the Company&rsquo;s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common
Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s
stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or practice
to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public
announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ll) <U>Cybersecurity</U>.&nbsp;
(i)(x) There has been no security breach or other compromise of or relating to any of the Company&rsquo;s or any Subsidiary&rsquo;s information
technology and computer systems, networks, hardware, software, data (including the data of its respective customers, employees, suppliers,
vendors and any third party data maintained by or on behalf of it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;)
and (y) the Company and the Subsidiaries have not been notified of, and has no knowledge of any event or condition that would reasonably
be expected to result in, any security breach or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are
presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator
or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security of IT Systems
and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as
would not, individually or in the aggregate, have a Material Adverse Effect; (iii)&nbsp;the Company and the Subsidiaries have implemented
and maintained commercially reasonable safeguards to maintain and protect its material confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster
recovery technology consistent with industry standards and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(mm) <U>Office
of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company's knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">(nn) <U>U.S. Real Property Holding
Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section 897 of the
Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(oo) <U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to
regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(pp) <U>Money
Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable
financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable
money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or
any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(qq) <U>No Disqualification
Events</U>. &nbsp;With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none
of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated
on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with the Company
in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer Covered Persons</U>&rdquo;)
is subject to any of the &quot;Bad Actor&quot; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has
exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied,
to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures
provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(rr) <U>Other
Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that
has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ss) <U>Notice
of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of
(i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a
Disqualification Event relating to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.2 <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) <U>Own
Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered under
the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with
a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state
securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state
securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution
of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable
federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7),
(a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule
144A(a) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) <U>General
Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any advertisement,
article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over
television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.&nbsp; Such Purchaser acknowledges and agrees that neither the
Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the
Securities nor is such information or advice necessary or desired.&nbsp; Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it.&nbsp; In connection with the issuance
of the Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary
to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales,&nbsp;of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The Company acknowledges and
agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on
the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties contained in any
other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation
of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute
a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or
similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.1 <U>Transfer
Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of
counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration
Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The
Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">THIS SECURITY HAS NOT BEEN REGISTERED
WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT
TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY MAY BE
PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT
IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured
Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal
opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall
be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation
as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including,
if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required
prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately
amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Certificates
evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while
a registration statement (including the Registration Statement) covering the resale of such security is effective under the Securities
Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 (assuming cashless exercise of the Warrants), (iii)
if such Shares or Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants), or (iv) if such legend
is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the
staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser if required
by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all or any portion
of a Warrant is exercised at a time when there is an effective registration statement to cover the resale of the Warrant Shares, or if
such Shares or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current public information required
under Rule 144 (assuming cashless exercise of the Warrants), or if the Shares or Warrant Shares may be sold under Rule 144 without the
requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Shares or Warrant
Shares or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations
and pronouncements issued by the staff of the Commission) then such Warrant Shares shall be issued free of all legends. The Company agrees
that at such time as such legend is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser
to the Company or the Transfer Agent of a certificate representing Shares or Warrant Shares, as the case may be, issued with a restrictive
legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing
such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Securities subject to legend
removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime
broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of a certificate representing Shares or Warrant Shares, as the case may be, issued
with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) In
addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day
(increasing to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend
Removal Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to
be delivered) to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such
Purchaser that is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an
open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion
of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of
shares of Common Stock that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal
to the excess of such Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any)
for the shares of Common Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<B><U>Buy-In
Price</U></B>&rdquo;) over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to such
Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during the
period commencing on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the case
may be) and ending on the date of such delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) Each
Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant
to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution
set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth
in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.2 <U>Furnishing
of Information; Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) If
the Common Stock is not registered under Section 12(b) or 12(g) of the Exchange Act on the date hereof, the Company agrees to cause the
Common Stock to be registered under Section 12(g) of the Exchange Act on or before the 60<SUP>th</SUP> calendar day following the date
hereof. Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants
to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) At
any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities
may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation
pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement under Rule 144(c)
or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company shall fail to satisfy
any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition to such Purchaser&rsquo;s
other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and not as a penalty, by reason
of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%) of the aggregate
Subscription Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every thirtieth (30<SUP>th</SUP>)
day (pro-rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure
is cured and (b) such time that such public information is no longer required&nbsp; for the Purchasers to transfer the Shares and Warrant
Shares pursuant to Rule 144.&nbsp; The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred to
herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo;&nbsp; Public Information Failure Payments shall be paid on the earlier
of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3<SUP>rd</SUP>)
Business Day after the event or failure giving rise to the Public Information Failure Payments is cured.&nbsp; In the event the Company
fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at
the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to
pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to
it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.3 <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes
of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other
transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.4 <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material terms of the
transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto,
with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company represents
to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the
Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions
contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges and
agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company, any
of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing
any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any
such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release
of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall
not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly
provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall
not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory
agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection
with (i) any registration statement contemplated by the Registration Rights Agreement and (ii) the filing of final Transaction Documents
with the Commission and (b) to the extent such disclosure is required by law or Trading Market regulations, in which case the Company
shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.5 <U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.6 <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company, any of its Subsidiaries, or
any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public information to a Purchaser
without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not have any duty of confidentiality
to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to
the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the
basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent that
any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company
or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The
Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.7 <U>Use
of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the sale of the
Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s
debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption
of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC
regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.8 <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions
contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct). If any action shall be brought against
any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify
the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent
that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a
material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable
to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company&rsquo;s prior written
consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage
or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations, warranties, covenants or agreements
made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.8
shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received
or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser
Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.9 <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue Shares
pursuant to this Agreement and Warrant Shares pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.10 <U>Listing
of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading
Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Shares
and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and Warrant Shares on such Trading Market.
The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in
such application all of the Shares and Warrant Shares, and will take such other action as is necessary to cause all of the Shares and
Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all action reasonably
necessary to continue the listing and trading of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s
reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility
of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including,
without limitation, by timely payment of fees to the Depository Trust Company or such other established clearing corporation in connection
with such electronic transfer. In addition, the Company shall hold a special meeting of shareholders (which may also be at the annual
meeting of shareholders) at the earliest practicable date after the date hereof, but in no event later than February 28, 2022 for the
purpose of obtaining Shareholder Approval, with the recommendation of the Company&rsquo;s Board of Directors that such proposal be approved,
and the Company shall solicit proxies from its shareholders in connection therewith in the same manner as all other management proposals
in such proxy statement and all management-appointed proxyholders shall vote their proxies in favor of such proposal. The Company shall
use its reasonable best efforts to obtain such Shareholder Approval. If the Company does not obtain Shareholder Approval at the first
meeting, the Company shall call a meeting every four (4) months thereafter to seek Shareholder Approval until the earlier of the date
Shareholder Approval is obtained or the Warrants are no longer outstanding. Notwithstanding the foregoing, the Company may, in lieu of
holding a special meeting of shareholders as aforesaid, obtain the written consent of a majority of its shareholders covering the Shareholder
Approval so long as prior to February 28, 2022, such written consents are obtained and in accordance with Exchange Act Rule 14c-2 at least
twenty (20) days shall have transpired from the date on which a written information statement containing the information specified in
Schedule 14C detailing such Shareholder Approval shall have been filed with the SEC and delivered to shareholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">4.11 <U>Subsequent
Equity Sales.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) From
the date hereof until sixty (60) days following the Effective Date pursuant to which all Shares and Warrant Shares are registered for
resale, neither the Company nor any Subsidiary shall (i) issue, enter into any agreement to issue or announce the issuance or proposed
issuance of any shares of Common Stock or Common Stock Equivalents other than as contemplated by this Agreement. or (ii) file any registration
statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration Rights Agreement;
provided, however, that neither the Company nor any Subsidiary shall effect any of the actions described in clauses (i) or (ii) of this
Section 4.11(a) with respect to an at-the-market offering for a period of six (6) months following the Effective Date pursuant to which
all Shares and Warrant Shares are registered for resale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) From
the date hereof until such time as no Purchaser holds any of the Warrants, the Company shall be prohibited from effecting or entering
into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents (or a combination
of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction in which the
Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or include the right
to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is
based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after the initial issuance
of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date
after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price. Notwithstanding
the foregoing definition of Variable Rate Transaction, an &ldquo;at-the-market&rdquo; offering of securities under an effective shelf
registration statement shall not be considered a Variable Rate Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Any
Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition
to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) Notwithstanding
the foregoing, this Section 4.11 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an
Exempt Issuance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.12 <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of Securities or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.13 <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it,
nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales,
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4.&nbsp; Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules.&nbsp;
Notwithstanding the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges
and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant
to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions
in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after
the issuance of the initial press release as described in Section 4.4.&nbsp; Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.14 <U>Form
D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.15 <U>Capital
Changes</U>. Until the one year anniversary of the Effective Date, the Company shall not undertake a reverse or forward stock split or
reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.16 <U>Acknowledgment
of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under
the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant to the Transaction
Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the
effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance
may have on the ownership of the other stockholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.17 <U>Exercise
Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of the Purchasers
in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required of the Purchasers
to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to exercise the
Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms, conditions
and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.18 <U>Lock-Up
Agreements</U>. The Company, on behalf of itself and any successor entity, has agreed in an underwriting agreement dated November 8, 2021
entered into with the Placement Agent as the representative for the underwriters listed therein (the &ldquo;<U>Underwriting Agreement</U>&rdquo;)
that, without the prior written consent of the Placement Agent, it will not, for a period of 180 days after the date of the Underwriting
Agreement (the &ldquo;<U>Lock-Up Period</U>&rdquo;), (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly
or indirectly, any shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares
of capital stock of the Company; (ii) file or caused to be filed any registration statement with the SEC relating to the offering of any
shares of capital stock of the Company or any securities convertible into or exercisable or exchangeable for shares of capital stock of
the Company; (iii) complete any offering of debt securities of the Company, other than entering into a line of credit with a traditional
bank or (iv) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences
of ownership of capital stock of the Company, whether any such transaction described in clause (i), (ii), (iii) or (iv) above is to be
settled by delivery of shares of capital stock of the Company or such other securities, in cash or otherwise. In addition, each of the
Company&rsquo;s directors, officers and stockholders as of November 8, 2021 has agreed that for a period of 180 days after the date thereof,
without the prior written consent of the Placement Agent, they will not, directly or indirectly,&nbsp;(i)&nbsp;offer, pledge, sell, contract
to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any common stock of the Company or any securities convertible
into or exercisable or exchangeable for the common stock of the Company, whether now owned or hereafter acquired by such person or with
respect to which such person has or hereafter acquires the power of disposition; (ii)&nbsp;enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of such securities; (iii)&nbsp;make any demand
for or exercise any right with respect to the registration of any such securities; or (iv)&nbsp;publicly disclose the intention to make
any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement relating to any such securities.
The Company agrees that if any party subject to the above-mentioned lock-up restrictions breaches any such provisions, the Company shall
promptly use its best efforts to seek specific performance of such terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.19 <U>Restrictions
on Issuances until Shareholder Approval</U>. Unless Shareholder Approval has been obtained and deemed effective, neither the Company nor
any Subsidiary shall make any issuance whatsoever of Common Stock or Common Stock Equivalents which would cause any adjustment of the
exercise price of the Warrants below $4.80 per share (subject to adjustment for reverse and forward stock splits, recapitalizations and
similar transactions following the date of the Purchase Agreement), ignoring for such purposes clause (i) of the definition of &ldquo;Floor
Price&rdquo; (as defined in the Warrants). Each Purchaser shall be entitled to obtain injunctive relief against the Company to preclude
any such issuance, which remedy shall be in addition to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ARTICLE V.</B><BR>
<B>MISCELLANEOUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.1 <U>Termination</U>.&nbsp;
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.2 <U>Fees
and Expenses</U>. At the Closing, the Company has agreed to (i) pay the Placement Agent a fee equal to 8% of the gross proceeds received
from the sale of the Common Stock and Warrants; (ii) issue the Placement Agent five-year Warrants to purchase such number of shares, at
$4.97 per share, as shall be equal to 3% of the shares sold in the offering; (iii) reimburse the Placement Agent for all of its accountable
expenses and (iv) pay the Placement Agent a non-accountable expense equal to 0.5% of the gross proceeds received by the Company at the
closing of this offering. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.3 <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.4 <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile
at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30
p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.5 <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares based on the initial
Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the party against
whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and
adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.6 <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.7 <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.8 <U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations and warranties of the Company
in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.9 <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.8, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.10 <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.11 <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page were an original
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.12 <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.13 <U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of
the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and
the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission of an exercise
of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice
concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance of a replacement
warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.14 <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.15 <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.16 <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none"></FONT></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.17 <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
Placement Agent Counsel. Placement Agent Counsel does not represent any of the Purchasers and only represents the Placement Agent. The
Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not
because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained
in this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and
the Purchasers collectively and not between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.18 <U>Liquidated
Damages</U>.&nbsp; The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.19 <U>Saturdays, Sundays,
Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted herein
shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.20 <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.21 <B><U>WAIVER
OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES
EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> IN WITNESS WHEREOF, the
parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the
date first indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3"><FONT STYLE="font: 10pt Times New Roman, Times, Serif; text-transform: uppercase"><B>stran &amp; company, inc.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for Notice:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 Heritage Drive, Suite 600</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quincy, MA 02171</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew Shape</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fax:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and President</FONT></TD>
    <TD>&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="5"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">With a copy to (which shall not constitute notice):</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">STRN</FONT>
SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
__________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _____________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory: ______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Securities to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount @$4.97 for one Share plus 1.25 Warrants: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Shares: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Warrants: ______________ Beneficial Ownership Blocker <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT>
4.99% or <FONT STYLE="font: 10pt Times New Roman, Times, Serif">&#9744;</FONT> 9.99%</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: _______________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF LEGAL OPINION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF REGISTRATION RIGHTS AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF COMMON STOCK PURCHASE WARRANTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(See Attached)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">44</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea152147ex10-2_stranandco.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT DATED DECEMBER 8, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">December 8, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stran &amp; Company, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2 Heritage Drive, Suite 600</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Quincy, MA 02171</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Attention: Andrew Shape, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Mr. Shape:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter (the &quot;<U>Agreement</U>&quot;)
constitutes the agreement between EF Hutton, division of Benchmark Investments, LLC (&quot;<U>EF Hutton</U>&quot; or the &quot;<U>Placement
Agent</U>&quot;) and Stran &amp; Company, Inc. (the &quot;<U>Company</U>&quot;), that EF Hutton shall serve as the exclusive placement
agent for the Company, on a &quot;reasonable best efforts&quot; basis, in connection with the proposed private placement (the &quot;<U>Placement</U>&quot;)
of Common Stock of the Company (the &quot;<U>Shares</U>&quot;), par value $0.0001 per share (the &quot;Common Stock&quot;) and warrants
to purchase Common Stock (the &quot;<U>Warrants</U>,&quot; the shares of Common Stock issuable upon exercise of the Warrants, the &quot;<U>Warrant
Shares</U>&quot; and the Shares, Warrants and Warrant Shares, collectively, the &quot;<U>Securities</U>&quot;). The terms of the Placement
shall be mutually agreed upon by the Company, EF Hutton and the purchasers of the Securities (each, a &quot;<U>Purchaser</U>&quot; and
collectively, the &quot;<U>Purchasers</U>&quot;) and nothing herein constitutes that EF Hutton would have the power or authority to bind
the Company or any Purchaser or an obligation for the Company to issue any Securities or complete the Placement. This Agreement and the
documents executed and delivered by the Company and the Purchasers in connection with the Placement, including, but not limited to, the
Purchase Agreement (as hereinafter defined) shall be collectively referred to herein as the &quot;<U>Transaction Documents</U>.&quot;
Each date on which there is a closing (each a &quot;<U>Closing</U>&quot;) of the Placement shall be referred to herein as a &quot;<U>Closing
Date</U>.&quot; The Company expressly acknowledges and agrees that EF Hutton's obligations hereunder are on a reasonable best efforts
basis only and that the execution of this Agreement does not constitute a legal or binding commitment by EF Hutton to purchase the Securities
or introduce the Company to investors and does not ensure the successful placement of the Securities or any portion thereof or the success
of EF Hutton with respect to securing any other financing on behalf of the Company. The Placement Agent may retain other brokers or dealers
to act as sub-agents or selected-dealers on its behalf in connection with the Placement. The sale of the Securities to any Purchaser will
be evidenced by a purchase agreement (the &quot;<U>Purchase Agreement</U>&quot;) between the Company and such Purchaser in a form reasonably
acceptable to the Company and EF Hutton. Prior to the signing of the Purchase Agreement, officers of the Company will be available to
answer inquiries from prospective Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything herein
to the contrary, in the event EF Hutton determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including
but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement in writing upon the request of EF Hutton to comply
with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise provided,
all dollar amount in this Agreement shall be U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 1. <U>COMPENSATION</U>.
As compensation for the services provided by EF Hutton hereunder, the Company agrees to pay to EF Hutton:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) A cash fee payable in
U.S. dollars equal to 8.0% of the gross proceeds received by the Company from Purchasers at each Closing (the &quot;<U>Cash Compensation</U>&quot;),
plus a fee of 0.5% of the gross proceeds raised for non-accountable expenses related to the offering. The Cash Compensation shall be paid
by wire transfer on the date of each Closing of the Placement from the gross proceeds of the Securities sold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) The Company, at each Closing,
will grant to EF Hutton warrants (the &quot;<U>Placement Warrants</U>&quot;) covering a number of the securities equal to the sum of three
percent (3.0%) of the total number of Shares issued in the Placement to the Purchasers (the &quot;<U>Warrant Shares</U>&quot;) issued
in the Placement at such Closing. The Placement Warrants will be exercisable six (6) months after the date of each Closing and expire
five (5) years after such Closing. The Placement Warrants will be initially exercisable at a price per share equal to the exercise price
of the Warrants issued in the Placement. Subject to FINRA Rule 5110, the Placement Agent will be entitled to the same registration rights
as the Purchasers. The Placement Warrants may be exercised in whole or in part, shall provide for &quot;cashless exercise&quot;, and shall
provide for customary anti-dilution protection for stock splits, combinations and the like.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(C) The Company also agrees
to reimburse EF Hutton at each Closing for all of EF Hutton's reasonable expenses, including, without limitation, fees and disbursements
of EF Hutton's counsel and all travel and other out-of-pocket expenses, incurred by EF Hutton in connection with the Placement up to $100,000.
In the event this Agreement shall terminate prior to the consummation of the Placement, EF Hutton shall be entitled to reimbursement of
its actual, out-of-pocket accountable expenses (including legal fees up to a maximum of $50,000) incurred by the Placement Agent in connection
with the Placement. Expenses will be reimbursed on the date of the initial Closing or, if there is no Closing, on or prior to the Termination
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 2.&#9;REPRESENTATIONS
AND WARRANTIES OF THE COMPANY. Each of the representations and warranties (together with any related disclosures in any disclosure schedules
appended thereto) made by the Company to the Purchasers in the Transaction Documents, is hereby incorporated herein by reference (as though
fully restated herein) and is, as of the date of this Agreement, hereby made to, and in favor of, the Placement Agent. In addition to
the foregoing, the Company represents and warrants to the Placement Agent that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) (i) the Company has full
right, power and authority to enter into this Agreement and to perform all of its obligations hereunder; (ii) this Agreement has been
duly authorized and executed and constitutes a legal, valid and binding agreement of such party enforceable in accordance with its terms;
and (iii) the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby does not conflict
with or result in a breach of (y) the Company's certificate of incorporation or by-laws or other charter documents or (z) any agreement
to which the Company is a party or by which any of its property or assets is bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) All disclosure provided
by the Company to the Placement Agent regarding the Company, its business and the transactions contemplated hereby, taken together with
all filings the Company has made with the Securities and Exchange Commission, is true and correct in all material aspects and does not
contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein,
in the light of the circumstances under which they were made, not misleading. Each filing made by the Company with the Securities and
Exchange Commission since October 7, 2021 did not at the time of release contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. To the best of the Company's knowledge and belief, other than the current capital raising
(of which this Agreement forms part), no event or circumstance has occurred or information exists with respect to the Company or its business,
properties, prospects, operations or financial conditions, which, under the applicable laws, rules or regulations, requires public disclosure
or announcement by the Company but which has not been so publicly announced or disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(C) The Company has not taken
and will not take any action, directly or indirectly, so as to cause the Placement to fail to be entitled to rely upon the exemption from
registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &quot;<U>Act</U>&quot;). In effecting the Placement,
the Company agrees to comply in all material respects with applicable provisions of the Act and any regulations thereunder and any applicable
laws, rules, regulations and requirements (including, without limitation, all U.S. state law and all national, provincial, city or other
legal requirements).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(D) The Company has the power
to submit, and pursuant to Section 9 of this Agreement, has legally, validly, effectively and irrevocably submitted, to the non-exclusive
personal jurisdiction of any New York State or United States federal court located in the City of New York, Borough of Manhattan, (each,
a &quot;<U>New York Court</U>&quot;). The Company has the power to designate, appoint and authorize, and pursuant to Section 9 of this
Agreement, has legally, validly, effectively and irrevocably designated, appointed an authorized agent for service of process in any action
arising out of or relating to this Agreement or the Placement in any New York Court, and service of process effected on such authorized
agent will be effective to confer valid personal jurisdiction over the Company as provided in Section 9 of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 3.
REPRESENTATIONS OF EF HUTTON. EF Hutton represents and warrants that it (i) is a member in good standing of FINRA, (ii) is
registered as a broker/dealer under the Securities Exchange Act of 1934, as amended, (iii) is licensed as a broker/dealer under the
laws of the states applicable to the offers and sales of the Securities by EF Hutton, (iv) is and will be a body corporate validly
existing under the laws of its place of incorporation; (v) has full power and authority to enter into and perform its obligations
under this Agreement, (vi) the Placement Agent has not taken and will not take any action, directly or indirectly, so as to cause
the Placement to fail to be entitled to rely upon the exemption from registration afforded by Section 4(a)(2) of the Act; (vii) in
effecting the Placement, the Placement Agent agrees to comply in all material respects with applicable provisions of the Act and any
regulations thereunder and any applicable laws, rules, regulations and requirements (including, without limitation, all U.S. state
law and all national, provincial, city or other legal requirements), (viii) this Agreement has been duly authorized and executed and
constitutes a legal, valid and binding agreement of EF Hutton enforceable in accordance with its terms, and (ix) neither the
Placement Agent, any person compensated for soliciting investors in the Placement, nor any general partner, managing member,
executive officer, director or officer of the Placement Agent participating in the Placement is subject to any of the &quot;<U>Bad
Actor</U>&quot; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &quot;<U>Disqualification
Event</U>&quot;), except for a Disqualification Event covered by Rule 506(d)(2). EF Hutton will immediately notify the Company in
writing of any change in its status as such. EF Hutton covenants that it will use its reasonable best efforts to conduct the
Transaction hereunder in compliance with the provisions of this Agreement and the requirements of applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 4.
INDEMNIFICATION. The Company agrees to the indemnification and other agreements set forth in the Indemnification Provisions (the
&quot;<U>Indemnification</U>&quot;) attached hereto as Addendum A, the provisions of which are incorporated herein by reference and
shall survive the termination or expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 5. ENGAGEMENT
TERM.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) This Agreement will remain
in effect until the earlier of (i) the Closing date of the Placement and (ii) the date a party terminates the engagement according with
the terms of the next sentence. The engagement may be terminated by either party on ten (10) days prior written notice to the other party
until a Closing has occurred. Following the final Closing of this Placement, this Agreement will automatically terminate. The date of
termination of this Agreement is referred to herein from time to time as the &quot;Termination Date.&quot; If, within six (6) months after
the Termination Date, the Company completes any financing of equity, equity-linked or debt or other capital raising activity of the Company
(other than the exercise by any person or entity of any options, warrants or other convertible securities other than any warrants issued
in connection with this Agreement) with any of the investors contacted by the Placement Agent in connection with the Placement (other
than Company Introduced Purchasers), the Company will pay to the Placement Agent upon the closing of such financing the compensation set
forth in Section 1 upon closing of such financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) Notwithstanding anything
herein to the contrary, subject to the six (6) months limitation described in Section 5(A) above, the obligation to pay the compensation
and expenses accruing prior to the Termination Date as described in Section 1, Section 4, this Section 5, Sections 9, 10 and 11 and all
of Exhibit A attached hereto (the terms of which are incorporated by reference hereto), will survive any termination or expiration of
this Agreement. The termination of this Agreement shall not affect the Company's obligation to pay fees to the extent provided for in
Section 1 herein and shall not affect the Company's obligation to reimburse the expenses accruing prior to such Termination Date to the
extent provided for herein. All such accrued fees and reimbursements due shall be paid to the Placement Agent on or before the Termination
Date (in the event such fees and reimbursements are earned or owed as of the Termination Date) or upon the Closing of the Placement or
any applicable portion thereof (in the event such fees are due pursuant to the terms of Section 1 hereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 6. EF HUTTON
INFORMATION. The Company agrees that any information or advice rendered by EF Hutton in connection with this engagement is for the
confidential use of the Company only in their evaluation of the Placement and, except as otherwise required by law, the Company will
not disclose or otherwise refer to the advice or information in any manner without EF Hutton's prior written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 7. NO FIDUCIARY
RELATIONSHIP; SECURITIES AND OTHER LAW COMPLIANCE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) This Agreement does not
create, and shall not be construed as creating rights enforceable by any person or entity not a party hereto, except those entitled hereto
by virtue of the Indemnification Provisions hereof. The Company acknowledges and agrees that EF Hutton is not and shall not be construed
as a fiduciary of the Company and shall have no duties or liabilities to the equity holders or the creditors of the Company or any other
person by virtue of this Agreement or the retention of EF Hutton hereunder, all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) The Company, at its own
expense, will use its best efforts to obtain any registration, qualification or approval required to sell any Securities under the laws
(including U.S. state &quot;<U>blue sky</U>&quot; laws) of any applicable jurisdictions (including those of Canada or any instrumentality
thereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 8.
[INTENTIONALLY OMITTED]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 9. CLOSING. The
obligations of the Placement Agent hereunder, and the closing of the sale of the Securities pursuant to the Purchase Agreement are subject
to the accuracy, when made and on each Closing Date, of the representations and warranties on the part of the Company and its subsidiaries
contained herein and in the Purchase Agreement, to the accuracy of the statements of the Company and its subsidiaries made in any certificates
pursuant to the provisions hereof, to the performance by the Company and its subsidiaries of their obligations hereunder, and to each
of the following additional terms and conditions, except as otherwise disclosed to and acknowledged by the Placement Agent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A) All corporate proceedings
and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement, the Securities
and all other legal matters relating to this Agreement and the transactions contemplated hereby shall be reasonably satisfactory in all
material respects to counsel for the Placement Agent, and the Company shall have furnished to such counsel all documents and information
that they may reasonably request to enable them to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B) The Placement Agent shall
have received as of each Closing Date the favorable opinions of legal counsel to the Company identified in the Purchase Agreement, dated
as of such Closing Date, addressed to the Placement Agent in form and substance satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(C) (i) Neither the Company
nor any of its subsidiaries shall have sustained, since the date of the latest audited financial statements included or incorporated by
reference in its reports publicly filed with the Securities and Exchange Commission, any material loss or interference with its business
from fire, explosion, flood, terrorist act or other calamity, whether or not covered by insurance, or from any labor dispute or court
or governmental action, order or decree, otherwise than as set forth in or contemplated by the Purchase Agreement and disclosure schedules
thereto and (ii) since such date there shall not have been any change in the capital stock or long-term debt of the Company or any of
its subsidiaries or any change, or any development involving a prospective change, in or affecting the business, general affairs, management,
financial position, stockholders' equity, results of operations or prospects of the Company and its subsidiaries, otherwise as set forth
in or contemplated by the Purchase Agreement and disclosure schedules thereto, the effect of which, in any such case described in clause
(i) or (ii), is, in the reasonable judgment of the Placement Agent, so material and adverse as to make it impracticable or inadvisable
to proceed with the sale or delivery of the Securities on the terms and in the manner contemplated by the Purchase Agreement and disclosure
schedules thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(D) Subsequent to the execution
and delivery of this Agreement and up to the Closing Date, there shall not have occurred any of the following: (i) trading in the Company's
securities generally on the applicable trading market shall have been suspended or minimum or maximum prices or maximum ranges for prices
shall have been established on any such exchange or such market by the Securities and Exchange Commission or by such exchange or by any
other regulatory body or governmental authority having jurisdiction, (ii) a banking moratorium shall have been declared by federal or
state authorities or a material disruption has occurred in commercial banking or securities settlement or clearance services in the United
States, (iii) the United States shall have become engaged in hostilities in which it is not currently engaged, the subject of an act of
terrorism, there shall have been an escalation in hostilities involving the United States, or there shall have been a declaration of a
national emergency or war by the United States, or (iv) there shall have occurred any other calamity or crisis or any change in general
economic, political or financial conditions in the United States or elsewhere, if the effect of any such event in clause (iii) or (iv)
makes it, in the sole and reasonable judgment of the Placement Agent, impracticable or inadvisable to proceed with the sale or delivery
of the Securities on the terms and in the manner contemplated by the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(E) No action shall have been
taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental agency or body which would,
as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect the business or operations of
the Company; and no injunction, restraining order or order of any other nature by any federal or state court of competent jurisdiction
shall have been issued as of the Closing Date which would prevent the issuance or sale of the Securities or materially and adversely affect
the business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(F) The Company shall have
entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force and effect and shall contain
representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(G) On or prior to the Closing
Date, the Company shall have furnished to the Placement Agent such further information, certificates and documents as the Placement Agent
may reasonably request, including a secretary certificate and officer certificate in form and substance reasonably acceptable to the Placement
Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All opinions, letters, evidence
and certificates mentioned above or elsewhere in this Agreement shall be deemed to be in compliance with the provisions hereof only if
they are in form and substance reasonably satisfactory to counsel for the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 10. GOVERNING
LAW. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to
agreements made and to be performed entirely in such State. This Agreement may not be assigned by either party without the prior
written consent of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their
respective successors and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or
any transaction or conduct in connection herewith is waived. Each of the Placement Agent and the Company: (i) agrees that any legal
suit, action or proceeding arising out of or relating to this Agreement and/or the transactions contemplated hereby shall be
instituted exclusively in New York Supreme Court, County of New York, or in the United States District Court for the Southern
District of New York, (ii) waives any objection which it may have or hereafter to the venue of any such suit, action or proceeding,
and (iii) irrevocably consents to the jurisdiction of the New York Supreme Court, County of New York, and the United States District
Court for the Southern District of New York in any such suit, action or proceeding. Each of the Placement Agent and the Company
further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding
in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New York and
agrees that service of process upon the Company mailed by certified mail to the Company's address shall be deemed in every respect
effective service of process upon the Company, in any such suit, action or proceeding, and service of process upon the Placement
Agent mailed by certified mail to the Placement Agent's address shall be deemed in every respect effective service process upon the
Placement Agent, in any such suit, action or proceeding. Nothing contained herein shall be deemed to limit in any way any right to
serve process in any manner permitted by law. If either party shall commence an action or proceeding to enforce any provisions of a
Transaction Document, the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorney's
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 11. ENTIRE
AGREEMENT/MISC. This Agreement (including the attached Indemnification Provisions) embodies the entire agreement and understanding
between the parties hereto, and supersedes all prior agreements and understandings, relating to the subject matter hereof. If any
provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such
provision in any other respect or any other provision of this Agreement, which will remain in full force and effect. This Agreement
may not be amended or otherwise modified or waived except by an instrument in writing signed by both EF Hutton and the Company. The
representations, warranties, agreements and covenants contained herein shall survive the closing of the Placement and delivery of
the Securities, as applicable. This Agreement may be executed in two or more counterparts, all of which when taken together shall be
considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is
delivered by facsimile transmission or a .pdf format file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf signature page
were an original thereof. The Company agrees that the Placement Agent may rely upon, and is a third party beneficiary of, the
representations and warranties, and applicable covenants set forth in any such purchase, subscription or other agreement with the
Purchasers in the Placement. For the avoidance of doubt, the right of first refusal provided to EF Hutton pursuant to the
Underwriting Agreement, dated November 8, 2021, by and between the Company and EF Hutton, shall remain in full force and effect in
accordance with its terms for the period set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 12. NOTICES. Any
and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email
address specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next
business day after the date of transmission, if such notice or communication is sent to the email address on the signature pages
attached hereto on a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third
business day following the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual
receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set
forth on the signature pages hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 13. SECURITIES
AND OTHER LAW COMPLIANCE. The Company, at its own expense, will use its best efforts to obtain any registration, qualification or approval
required to sell any securities under the laws (including U.S. state &quot;blue-sky&quot; laws) of any applicable jurisdictions or any
instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 14. PRESS
ANNOUNCEMENTS. The Company agrees that the Placement Agent shall, from and after any Closing, have the right to reference the
Placement and the Placement Agent's role in connection therewith in the Placement Agent's marketing materials and on its website and
to place advertisements in financial and other newspapers and journals, in each case at its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SECTION 15.
CONFIDENTIALITY. The Placement Agent (i) will keep the Confidential Information (as such term is defined below) confidential and
will not (except as required by applicable law or stock exchange requirement, regulation or legal process (&quot;<U>Legal
Requirement</U>&quot;)), without the Company's prior written consent, disclose to any person any Confidential Information, and (ii)
will not use any Confidential Information other than in connection with the Placement. The Placement Agent further agrees to
disclose the Confidential Information only to its Representatives (as such term is defined below) who need to know the Confidential
Information for the purpose of the Placement, and who are informed by the Placement Agent of the confidential nature of the
Confidential Information. The term &quot;<U>Confidential Information</U>&quot; shall mean, all confidential, proprietary and
non-public information (whether written, oral or electronic communications) furnished by the Company to the Placement Agent or its
Representatives in connection with the Placement Agent's evaluation of the Placement. The term &quot;Confidential Information&quot;
will not, however, include information which (i) is or becomes publicly available other than as a result of a disclosure by the
Placement Agent or its Representatives in violation of this Agreement, (ii) is or becomes available to the Placement Agent or any of
its Representatives on a non-confidential basis from a third-party, (iii) is known to the Placement Agent or any of its
Representatives prior to disclosure by the Company or any of its Representatives, or (iv) is or has been independently developed by
the Placement Agent and/or the Representatives without use of any Confidential Information furnished to it by the Company. The term
&quot;Representatives&quot; shall mean the Placement Agent's directors, board committees, officers, employees, financial advisors,
attorneys and accountants. This provision shall be in full force until the earlier of (a) the date that the Confidential Information
ceases to be confidential and (b) two (2) years from the date hereof. Notwithstanding any of the foregoing, in the event that the
Placement Agent or any of its Representatives are required by Legal Requirement to disclose any of the Confidential Information, the
Placement Agent and its Representatives will furnish only that portion of the Confidential Information which the Placement Agent or
its Representative, as applicable, is required to disclose by Legal Requirement as advised by counsel, and will use reasonable
efforts to obtain reliable assurance that confidential treatment will be accorded the Confidential Information so disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>The remainder of this
page has been intentionally left blank.</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please confirm that the foregoing
correctly sets forth our agreement by signing and returning to EF Hutton the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left">Very</TD><TD STYLE="text-align: justify">truly yours,</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EF HUTTON</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Sam Fleischman</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sam Fleischman</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supervisory Principal</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for notice:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">590 Madison Avenue, 39th Floor</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10022</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Joseph Rallo</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: jrallo@efhuttongroup.com</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD></TD><TD COLSPAN="2" STYLE="text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Accepted</FONT> <FONT STYLE="font: 10pt Times New Roman, Times, Serif">and Agreed to as of the date first written above:</FONT></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in">&nbsp;</TD><TD STYLE="text-align: left; width: 0.25in">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD COLSPAN="2" STYLE="text-align: left">STRAN &amp; COMPANY, INC.</TD></TR>
     </TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.75in">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Andrew Shape</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andrew Shape</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for notice:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2 Heritage Drive, Suite 600</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quincy, MA 02171</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Andrew Shape, Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: andyshape@stran.com</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ADDENDUM A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INDEMNIFICATION PROVISIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used in
this Addendum shall have the meanings ascribed to such terms in the Agreement to which this Addendum is attached:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to and without
limiting any other right or remedy available to the Placement Agent and the Indemnified Parties (as hereinafter defined), the Company
agrees to indemnify and hold harmless Placement Agent and each of the other Indemnified Parties from and against any and all losses, claims,
damages, obligations, penalties, judgments, awards, liabilities, costs, expenses and disbursements, and any and all actions, suits, proceedings
and investigations in respect thereof and any and all legal and other costs, expenses and disbursements in giving testimony or furnishing
documents in response to a subpoena or otherwise (including, without limitation, the reasonable costs, expenses and disbursements, as
and when incurred, of investigating, preparing, pursing or defending any such action, suit, proceeding or investigation (whether or not
in connection with litigation in which any Indemnified Party is a party)) (collectively, &quot;<U>Losses</U>&quot;), directly or indirectly,
caused by, relating to, based upon, arising out of, or in connection with, Placement Agent's acting for the Company, including, without
limitation, any act or omission by Placement Agent in connection with its acceptance of or the performance or non-performance of its obligations
under the Agreement between the Company and Placement Agent to which these indemnification provisions are attached and form apart, any
breach by the Company of any representation, warranty, covenant or agreement contained in the Agreement (or in any instrument, document
or agreement relating thereto, including any agency agreement), or the enforcement by Placement Agent of its rights under the Agreement
or these indemnification provisions, except to the extent that any such Losses are found in a final judgment by a court of competent jurisdiction
(not subject to further appeal) to have resulted primarily and directly from the gross negligence or willful misconduct of the Indemnified
Party seeking indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company also agrees that
no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company for or in
connection with the engagement of Placement Agent by the Company or for any other reason, except to the extent that any such liability
is found in a final judgment by a court of competent jurisdiction (not subject to further appeal) to have resulted primarily and directly
from such Indemnified Party's gross negligence or willful misconduct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These Indemnification Provisions
shall extend to the following persons (collectively, the &quot;<U>Indemnified Parties</U>&quot;): Placement Agent, its present and former
affiliated entities, managers, members, officers, employees, legal counsel, agents and controlling persons (within the meaning of the
federal securities laws), and the officers, directors, partners, stockholders, members, managers, employees, legal counsel, agents and
controlling persons of any of them. These indemnification provisions shall be in addition to any liability, which the Company may otherwise
have to any Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any action, suit, proceeding
or investigation is commenced, as to which an Indemnified Party proposes to demand indemnification, it shall notify the Company with reasonable
promptness; provided, however, that any failure by an Indemnified Party to notify the Company shall not relieve the Company from its obligations
hereunder unless the Indemnified Party's ability to defend such action, suit, proceeding or investigation is materially impaired by such
failure. If counsel for an Indemnified Party reasonably determines that it would be inappropriate under the applicable rules of professional
responsibility for the same counsel to represent both the Company and the Indemnified Party, the Indemnified Party shall have the right
to retain a separate counsel of its own choice to represent it, and the fees, expenses and disbursements of no more than one such separate
counsel shall be borne by the Company. Any such counsel shall, to the extent consistent with its professional responsibilities, cooperate
with the Company and any counsel designated by the Company. The Company shall be liable for any settlement of any claim against any Indemnified
Party made with the Company's written consent. The Company shall not, without the prior written consent of Placement Agent, settle or
compromise any claim, or permit a default or consent to the entry of any judgment in respect thereof, unless such settlement, compromise
or consent (i) includes, as an unconditional term thereof, the giving by the claimant to all of the Indemnified Parties of an unconditional
release from all liability in respect of such claim, and (ii) does not contain any factual or legal admission by or with respect to an
Indemnified Party or an adverse statement with respect to the character, professionalism, expertise or reputation of any Indemnified Party
or any action or inaction of any Indemnified Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to provide for just
and equitable contribution, if a claim for indemnification pursuant to these indemnification provisions is made but it is found in a final
judgment by a court of competent jurisdiction (not subject to further appeal) that such indemnification may not be enforced in such case,
even though the express provisions hereof provide for indemnification in such case, then the Company shall contribute to the Losses to
which any Indemnified Party may be subject (i) in accordance with the relative benefits received by the Company and its stockholders,
subsidiaries and affiliates, on the one hand, and the Indemnified Party, on the other hand, and (ii) if (and only if) the allocation provided
in clause (i) of this sentence is not permitted by applicable law, in such proportion as to reflect not only the relative benefits, but
also the relative fault of the Company, on the one hand, and the Indemnified Party, on the other hand, in connection with the statements,
acts or omissions which resulted in such Losses as well as any relevant equitable considerations. No person found liable for a fraudulent
misrepresentation shall be entitled to contribution from any person who is not also found liable for fraudulent misrepresentation. The
relative benefits received (or anticipated to be received) by the Company and its stockholders, subsidiaries and affiliates shall be deemed
to be equal to the aggregate consideration payable or receivable by such parties in connection with the transaction or transactions to
which the Agreement relates relative to the amount of fees actually received by Placement Agent in connection with such transaction or
transactions. Notwithstanding the foregoing, in no event shall the amount contributed by all Indemnified Parties exceed the amount of
fees previously received by Placement Agent pursuant to the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither termination nor completion
of the Agreement shall affect these Indemnification Provisions which shall remain operative and in full force and effect. The Indemnification
Provisions shall be binding upon the Company and its successors and assigns and shall inure to the benefit of the Indemnified Parties
and their respective successors, assigns, heirs and personal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>
<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center">11</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ea152147ex10-3_stranandco.htm
<DESCRIPTION>FORM OF REGISTRATION RIGHTS AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.3&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION RIGHTS AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Registration Rights
Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of December 8, 2021, between Stran &amp; Company, Inc., a
Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser, a &ldquo;<U>Purchaser</U>&rdquo;
and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Agreement is made pursuant
to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and each Purchaser
hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.&nbsp;<U>Definitions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase
Agreement.</B>&nbsp;As used in this Agreement, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 30<SUP>th</SUP>&nbsp;calendar
day following the date hereof and with respect to any additional Registration Statements which may be required pursuant to Section 2(c)
or Section 3(c), the 30<SUP>th</SUP>&nbsp;calendar day following the date on which an additional Registration Statement is required to
be filed;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that in the event the Company is notified by the Commission that one or more of
the above Registration Statements will not be reviewed or is no longer subject to further review and comments, the Effectiveness Date
as to such Registration Statement shall be the fifth Trading Day following the date on which the Company is so notified if such date
precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls on a day that is not a Trading Day,
then the Effectiveness Date shall be the next succeeding Trading Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the 15<SUP>th</SUP>&nbsp;calendar day following
the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related
to the Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Plan
of Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Shares, (b) all Warrant Shares then issued and issuable upon exercise
of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein) and (c)
any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect
to the foregoing;&nbsp;<U>provided, however</U>, that any such Registrable Securities shall cease to be Registrable Securities (and the
Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder with respect thereto)
for so long as (a) a Registration Statement with respect to the sale of such Registrable Securities is declared effective by the Commission
under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance with such effective Registration
Statement, (b) such Registrable Securities have been previously sold in accordance with Rule 144, or (c) such securities become eligible
for resale without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 as set forth in
a written opinion letter to such effect, addressed, delivered and acceptable to the Transfer Agent and the affected Holders (assuming
that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon which, such securities
were issued or are issuable, were at no time held by any Affiliate of the Company), as reasonably determined by the Company, upon the
advice of counsel to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule
415</U>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Guidance</U>&rdquo;
means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements or requests of the Commission
staff and (ii) the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.&nbsp;<U>Shelf Registration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) On or prior
to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale of all of the
Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on a continuous
basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible
to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in
accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85% in interest
of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as&nbsp;<U>Annex A</U>&nbsp;and substantially
the &ldquo;<U>Selling Stockholder</U>&rdquo; section attached hereto as&nbsp;<U>Annex B</U>;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that no Holder shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent.
Subject to the terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement
(including, without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the
filing thereof, but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration
Statement continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration
Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant
to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule
144 (assuming that such securities and any securities issuable upon exercise, conversion or exchange of which, or as a dividend upon
which, such securities were issued or are issuable, were at no time held by any Affiliate of the Company), as determined by the counsel
to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer Agent and the affected Holders
(the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness of a Registration Statement as
of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via facsimile or by e-mail of the
effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness with the Commission,
which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m. (New York City time)
on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission as required by
Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure to file a final
Prospectus as foresaid shall be deemed an Event under Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) Notwithstanding
the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities
cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration statement,
the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments to the
Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted to be registered
by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary offering,
subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the provisions
of Section 2(d) with respect to the payment of liquidated damages;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that prior to filing such
amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the registration of all of the
Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation 612.09.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Notwithstanding
any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission or
any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular Registration
Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the
registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its Registrable
Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">a.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">First,
                                            the Company shall reduce or eliminate any securities to be included other than Registrable
                                            Securities;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">b.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Second,
                                            the Company shall reduce Registrable Securities represented by Warrant Shares (applied, in
                                            the case that some Warrant Shares may be registered, to the Holders on a pro rata basis based
                                            on the total number of unregistered Warrant Shares held by such Holders); and</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">c.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Third,
                                            the Company shall reduce Registrable Securities represented by Shares (applied, in the case
                                            that some Shares may be registered, to the Holders on a pro rata basis based on the total
                                            number of unregistered Shares held by such Holders).</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">In the event of a cutback hereunder,
the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder&rsquo;s
allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will use
its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company or to registrants
of securities in general, one or more registration statements on Form S-3 or such other form available to register for resale those Registrable
Securities that were not registered for resale on the Initial Registration Statement, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) If: (i) the
Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration Statement without
affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company shall be deemed
to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration
Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date
that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not
be &ldquo;reviewed&rdquo; or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement,
the Company fails to file a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of
such Registration Statement within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment
is required in order for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale
all of the Registrable Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement,
or (v) after the effective date of a Registration Statement and during the Effectiveness Period, such Registration Statement ceases for
any reason to remain continuously effective as to all Registrable Securities included in such Registration Statement, or the Holders
are otherwise not permitted to utilize the Prospectus therein to resell such Registrable Securities, for more than ten (10) consecutive
calendar days or more than an aggregate of fifteen (15) calendar days (which need not be consecutive calendar days) during any 12-month
period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;, and for purposes of clauses (i) and (iv), the
date on which such Event occurs, and for purpose of clause (ii) the date on which such five (5) Trading Day period is exceeded, and for
purpose of clause (iii) the date which such ten (10) calendar day period is exceeded, and for purpose of clause (v) the date on which
such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred to as &ldquo;<U>Event Date</U>&rdquo;),
then, in addition to any other rights the Holders may have hereunder or under applicable law, on each such Event Date and on each monthly
anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured,
the Company shall pay to each Holder an amount in cash, as partial liquidated damages and not as a penalty, equal to the product of 2.0%
multiplied by the aggregate Subscription Amount paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any
partial liquidated damages pursuant to this Section in full within seven days after the date payable, the Company will pay interest thereon
at a rate of 18% per annum (or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily
from the date such partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial
liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of
an Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) If Form S-3
is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the resale of
the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3 as soon
as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect until
such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) Notwithstanding
anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate of a Holder as
any Underwriter without the prior written consent of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.&nbsp;Registration <U>Procedures</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-align: justify; text-indent: 0.75in">In connection
with the Company&rsquo;s registration obligations hereunder, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a) Not less than
five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to the filing of
any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed to be incorporated
therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed, which documents
(other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders, and (ii) cause
its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary,
in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning of the Securities
Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto to which the
Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is notified of
such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration Statement
or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements thereto.
Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as&nbsp;<U>Annex B&nbsp;</U>(a
&ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing Date
or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance
with this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) (i) Prepare
and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus used
in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) If during the
Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock then registered
in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to the applicable Filing
Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) Notify the
Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied by an
instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible (and,
in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm such
notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus;&nbsp;<U>provided</U>,&nbsp;<U>however</U>,
that in no event shall any such notice contain any information which would constitute material, non-public information regarding the
Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) Use its best
efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness of a
Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities
for sale in any jurisdiction, at the earliest practicable moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f) Furnish to
each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including financial
statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested by such
Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly
after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or successor
thereto) need not be furnished in physical form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g) Subject to
the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each
of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment
or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h) Prior to any
resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate with the selling
Holders in connection with the registration or qualification (or exemption from the Registration or qualification) of such Registrable
Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United States as any Holder
reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness
Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions of the Registrable
Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally to do business
in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction where it is not
then so subject or file a general consent to service of process in any such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) If requested
by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable Securities
to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by the
Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j) Upon the occurrence
of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into account the Company&rsquo;s
good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event, prepare
a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to the related Prospectus
or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter
delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which
they were made, not misleading.&nbsp;If the Company notifies the Holders in accordance with clauses (iii) through (vi) of Section 3(d)
above to suspend the use of any Prospectus until the requisite changes to such Prospectus have been made, then the Holders shall suspend
use of such Prospectus. The Company will use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as
is practicable. The Company shall be entitled to exercise its right under this Section 3(j) to suspend the availability of a Registration
Statement and Prospectus, subject to the payment of partial liquidated damages otherwise required pursuant to Section 2(d), for a period
not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k) Otherwise use
commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities Act and the
Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or
amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing if, at any
time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the
Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l) After becoming
eligible to use Form S-3, the Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto)
for the registration of the resale of Registrable Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m) The Company
may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock beneficially
owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control over the
shares. The Company&rsquo;s obligation to register any Registrable Securities of a Holder is conditioned upon such Holder providing the
information required by this Agreement within the time periods set forth herein and during any periods that the Company is unable to
meet its obligations hereunder with respect to the registration of the Registrable Securities solely because any Holder fails to furnish
such information within three Trading Days of the Company&rsquo;s request, any liquidated damages that are accruing at such time as to
such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall be suspended as to such Holder
only, until such information is delivered to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4.&nbsp;<U>Registration Expenses</U>. All fees
and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne by the Company whether or
not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence
shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses of the Company&rsquo;s
counsel and independent registered public accountants) (A) with respect to filings made with the Commission, (B) with respect to filings
required to be made with any Trading Market on which the Common Stock is then listed for trading, and (C) in compliance with applicable
state securities or Blue Sky laws reasonably agreed to by the Company in writing (including, without limitation, fees and disbursements
of counsel for the Company in connection with Blue Sky qualifications or exemptions of the Registrable Securities), (ii) printing expenses
(including, without limitation, expenses of printing certificates for Registrable Securities), (iii) messenger, telephone and delivery
expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability insurance, if the Company so desires such
insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection with the consummation of the transactions
contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection
with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of
its officers and employees performing legal or accounting duties), the expense of any annual audit and the fees and expenses incurred
in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. In no event shall the
Company be responsible for any broker or similar commissions of any Holder or, except to the extent provided for in the Transaction Documents,
any legal fees or other costs of the Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">5.&nbsp;<U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Indemnification
by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder, the
officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal as
a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and any other
Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title)
of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with a functionally
equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such controlling Person,
to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including,
without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as incurred, in investigating,
preparing or defending against any litigation, commenced or threatened, or any claim arising out of or relating to (1) any untrue or
alleged untrue statement of a material fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any
amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of
a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement
thereto, in light of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company
of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance
of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue or alleged untrue statements
or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for
use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution of
Registrable Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement,
such Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose)
or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated,
defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated,
defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section
6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection
with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect
regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities
by any of the Holders in accordance with Section 6(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Indemnification
by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers, agents
and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange
Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted by applicable law,
from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged untrue statement of
a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto or in any preliminary
prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary
to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were
made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained in any information
so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such Prospectus or (ii)
to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in the Selling Stockholder
Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly approved in writing by
such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex A hereto for this purpose),
such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder be greater in amount than
the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and
the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or omission) received by
such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such indemnification obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Conduct
of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the
&ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense thereof, including
the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred in connection
with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying Party
of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that such failure shall have materially
and adversely prejudiced the Indemnifying Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">An Indemnified
Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the fees
and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party has agreed
in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such Proceeding
and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to any such
Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to the Indemnified
Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent such Indemnified
Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects
to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense
thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying Party).
The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent
shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified Party,
effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Subject to the
terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent
incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall
be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Contribution</U>.
If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified Party
harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified Party, in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions,
statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative fault of such
Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including
any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has been taken or made
by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative intent, knowledge,
access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party
as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any reasonable attorneys&rsquo;
or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified
for such fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The parties hereto
agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata allocation or
by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the dollar amount
of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the amount of any
damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission)
received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The indemnity and
contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to the Indemnified
Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Remedies</U>.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder or the
Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including
recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder
agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the
provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach,
it shall not assert or shall waive the defense that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Except as set forth on&nbsp;<U>Schedule 6(b)</U>&nbsp;attached
hereto, neither the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities
of the Company in any Registration Statements other than the Registrable Securities. The Company shall not file any other registration
statements until all Registrable Securities are registered pursuant to a Registration Statement that is declared effective by the Commission,
provided that this Section 6(b) shall not prohibit the Company from filing amendments to registration statements filed prior to the date
of this Agreement so long as no new securities are registered on any such existing registration statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Discontinued
Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of
the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition
of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;) by the
Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use
its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be
subject to the provisions of Section 2(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Amendments
and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed by
the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification, this includes
any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification or waiver
disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder (or group
of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to a waiver or
amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each Holder shall
be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities shall be
omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with
respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly affect
the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver or
consent relates;&nbsp;<U>provided</U>,&nbsp;<U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as set forth
in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Successors
and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the
parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations hereunder
without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign their
respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>No
Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the Company
or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities, that would
have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions hereof. Except
as set forth on&nbsp;<U>Schedule 6(i)</U>, neither the Company nor any of its Subsidiaries has previously entered into any agreement
granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>Execution
and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission
or by e-mail delivery of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature
page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined in
accordance with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Cumulative
Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Headings</U>.
The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or
affect any of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Independent
Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint with the obligations
of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder
hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any Holder
pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture or any other
kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity with respect
to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges that the Holders
are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations or transactions.
Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out of this Agreement,
and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such purpose. The use of
a single agreement with respect to the obligations of the Company contained was solely in the control of the Company, not the action
or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested to do
so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a
Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Signature Pages Follow)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
have executed this Registration Rights Agreement as of the date first written above</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">STRAN &amp; COMPANY, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE OF HOLDERS TO STRN RRA]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Holder:__________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Signature of Authorized Signatory of Holder:<U>&nbsp;___________________________________________________</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Name of Authorized Signatory:<U>&nbsp;______________________________________________________________</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Title of Authorized Signatory: _______________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGES CONTINUE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><U>Annex A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Plan of Distribution</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Selling Stockholder
(the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest may,
from time to time, sell any or all of their securities covered hereby on the Trading Market or any other stock exchange, market or trading
facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder
may use any one or more of the following methods when selling securities:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">ordinary brokerage transactions
and transactions in which the broker-dealer solicits purchasers;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">block trades in which the broker-dealer
will attempt to sell the securities as agent but may position and resell a portion of the block as principal to facilitate the transaction;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">purchases by a broker-dealer
as principal and resale by the broker-dealer for its account;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">an exchange distribution in
accordance with the rules of the applicable exchange;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">privately negotiated transactions;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">settlement of short sales;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">in transactions through broker-dealers
that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated price per security;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">through the writing or settlement
of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">a combination of any such methods
of sale; or</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">any other method permitted pursuant
to applicable law.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933, as amended (the &ldquo;<U>Securities
Act</U>&rdquo;), if available, rather than under this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broker-dealers engaged by
the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts
from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts
to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess of
a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown
in compliance with FINRA Rule 2121.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the sale
of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers or other financial
institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling
Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities
to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option or other transactions with
broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer
or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution
may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Selling Stockholders
and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo; within the
meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents
and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the
Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is required to
pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company has agreed to indemnify
the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We agreed to keep this prospectus
effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders without registration and
without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance
with the current public information under Rule 144 under the Securities Act or any other rule of similar effect or (ii) all of the securities
have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule of similar effect. The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition,
in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the
applicable state or an exemption from the registration or qualification requirement is available and is complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable rules and
regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in
market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M, prior to
the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the Exchange
Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the common
stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Annex B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SELLING SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The common stock being offered
by the selling shareholders are those previously issued to the selling shareholders, and those issuable to the selling shareholders,
upon exercise of the warrants. For additional information regarding the issuances of those shares of common stock and warrants, see &ldquo;Private
Placement of Shares of Common Stock and Warrants&rdquo; above. We are registering the shares of common stock in order to permit the selling
shareholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the warrants,
the selling shareholders have not had any material relationship with us within the past three years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The table below lists the
selling shareholders and other information regarding the beneficial ownership of the shares of common stock by each of the selling shareholders.
The second column lists the number of shares of common stock beneficially owned by each selling shareholder, based on its ownership of
the shares of common stock and warrants, as of ________, 2021, assuming exercise of the warrants held by the selling shareholders on
that date, without regard to any limitations on exercises.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of common stock being offered by this prospectus by the selling shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale of the sum of (i) the number
of shares of common stock issued to the selling shareholders in the &ldquo;Private Placement of Shares of Common Stock and Warrants&rdquo;
described above and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants, determined as if
the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement was
initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject to
adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The fourth
column assumes the sale of all of the shares offered by the selling shareholders pursuant to this prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the terms of the warrants,
a selling shareholder may not exercise the warrants to the extent such exercise would cause such selling shareholder, together with its
affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99% or 9.99%, as applicable,
of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable
upon exercise of such warrants which have not been exercised. The number of shares in the second and fourth columns do not reflect this
limitation. The selling shareholders may sell all, some or none of their shares in this offering. See &ldquo;Plan of Distribution.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; width: 29%; border-bottom: black 1.5pt solid"><P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><B><BR>
    <BR>
    Name of Selling Shareholder</B></P></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 23%; padding-right: 10.5pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number
    of shares of Common Stock Owned Prior to Offering</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 24%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Maximum Number of shares
    of Common Stock to be Sold Pursuant to this Prospectus</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 21%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number of shares of
    Common Stock Owned After Offering</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Annex C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>STRAN
&amp; COMPANY, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Selling Stockholder Notice and Questionnaire</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Stran &amp; Company, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;),
understands that the Company has filed or intends to file with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration and resale under Rule 415 of the Securities
Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities, in accordance with the terms of the
Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this document is annexed. A copy of the
Registration Rights Agreement is available from the Company upon request at the address set forth below. All capitalized terms not otherwise
defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain legal consequences
arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly, holders and beneficial
owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not being named as a selling stockholder in the Registration Statement and the related prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned beneficial
owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable Securities owned
by it in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby provides the following
information to the Company and represents and warrants that such information is accurate:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>QUESTIONNAIRE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>1. Name.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Selling Stockholder</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Registered Holder (if not the same as (a) above)
    through which Registrable Securities are held:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Full Legal Name of Natural Control Person (which means a natural person
    who directly or indirectly alone or with others has power to vote or dispose of the securities covered by this Questionnaire):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>2. Address for Notices to Selling Stockholder:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1.5pt solid; padding-right: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-right: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; padding-right: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font-size: 10pt">Telephone:<U>&nbsp;_____________________________________________________________________________________</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font-size: 10pt">Fax:<U>&nbsp;___________________________________________________________________________________________</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt"><FONT STYLE="font-size: 10pt">Contact Person:<U>&nbsp;__________________________________________________________________________________</U></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>3. Broker-Dealer Status:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Are you a broker-dealer?</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>&nbsp;&nbsp;
No&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px"><FONT STYLE="font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable
    Securities as compensation for investment banking services to the Company?</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="width: 86%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;no&rdquo; to Section 3(b), the
    Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Are you an affiliate of a broker-dealer?</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">If you are an affiliate of a broker-dealer, do you
    certify that you purchased the Registrable Securities in the ordinary course of business, and at the time of the purchase of the
    Registrable Securities to be resold, you had no agreements or understandings, directly or indirectly, with any person to distribute
    the Registrable Securities?</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Yes&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT>&nbsp;&nbsp;No&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 7%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="width: 86%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">If &ldquo;no&rdquo; to Section 3(d), the
    Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>4. Beneficial Ownership of Securities
of the Company Owned by the Selling Stockholder.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below in this
Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than the securities issuable
pursuant to the Purchase Agreement.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 48px">&nbsp;</TD>
    <TD STYLE="width: 48px; font-size: 10pt"><FONT STYLE="font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Type and Amount of other securities beneficially owned
    by the Selling Stockholder:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; padding-bottom: 1pt; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"><B>5. Relationships with the Company:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><I>Except as set forth below, neither
the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5% of more of the equity securities
of the undersigned) has held any position or office or has had any other material relationship with the Company (or its predecessors
or affiliates) during the past three years.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 94%; text-align: justify"><FONT STYLE="font-size: 10pt">State any exceptions here:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned agrees to
promptly notify the Company of any material inaccuracies or changes in the information provided herein that may occur subsequent to the
date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall not be required to notify
the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By signing below, the undersigned
consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and the inclusion of such information
in the Registration Statement and the related prospectus and any amendments or supplements thereto. The undersigned understands that
such information will be relied upon by the Company in connection with the preparation or amendment of the Registration Statement and
the related prospectus and any amendments or supplements thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF the undersigned,
by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either in person or by its duly authorized
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">Beneficial Owner:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 16%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PLEASE FAX A COPY (OR EMAIL A .PDF COPY) OF
THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">19<B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ea152147ex10-4_stranandco.htm
<DESCRIPTION>FORM OF PURCHASER WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">NEITHER THIS SECURITY NOR THE
SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMMON STOCK PURCHASE WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Stran
&amp; Company, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Warrant Shares: ______</FONT></TD>
<TD STYLE="width: 40%; font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Initial Exercise Date: December 10, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="font-size: 10pt">&nbsp;</TD>
<TD STYLE="font-size: 10pt"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Termination Date: December 10, 2026</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This <B>COMMON STOCK PURCHASE
WARRANT </B>(the &ldquo;Warrant&rdquo;) certifies that, for value received, _____________________ or its assigns (the &ldquo;Holder&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the date referred to above as the Initial Exercise Date (the &ldquo;Initial Exercise Date&rdquo;) and on or prior to 5:00 p.m. (New York
City time) on December 10, 2026 (the &ldquo;Termination Date&rdquo;) but not thereafter, to subscribe for and purchase from Stran &amp;
Company, Inc., a Nevada corporation (the &ldquo;Company&rdquo;), up to ____ shares (as subject to adjustment hereunder, the &ldquo;Warrant
Shares&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price,
as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>. <U>Definitions</U>.
Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Securities Purchase Agreement
(the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated December 8, 2021, among the Company and the purchasers listed in the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by email (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;Notice of Exercise&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless the cashless
exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise
shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required.
Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company
until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case,
the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of
Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in
an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number
of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of Exercise within one
(1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $4.97, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in part,
at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant Shares equal
to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt">(A) = as applicable:
(i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1)
both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant
to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading
Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading
Market as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a)
hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and
such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">(B) = the Exercise
Price of this Warrant, as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">(X) = the number
of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were
by means of a cash exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted
for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar organization
or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d)
in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith
by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and
expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b)&nbsp; if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported in The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock
so reported, or (d)&nbsp;in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser
selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the
Company, the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period of the Warrant
Shares being issued may be tacked on to the holding period of this Warrant.&nbsp;&nbsp;The Company agrees not to take any position contrary
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d)
<U>Mechanics of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust Company
through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system
and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the Warrant
Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations pursuant
to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in the Company&rsquo;s
share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to
such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading
Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price
to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the
Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder
shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant
has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price
(other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading
Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver
to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder,
in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of
the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third
Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares
are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program
so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the
standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common
Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by its
broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares of Common
Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise
(a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds (y) the amount obtained
by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise
at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the
Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in
which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been
issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common
Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with
an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the
Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit
a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares of Common Stock
upon exercise of the Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">vi. <U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent
fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company (or another established clearing
corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any
group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder may
rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion
or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date
as of which such number of outstanding shares of Common Stock was reported. The &ldquo;Beneficial Ownership Limitation&rdquo; shall be 4.99%
(or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company,
may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation
in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares
of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any
increase in the Beneficial Ownership Limitation will not be effective until the 61stday after such notice is delivered to the Company.
The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of
this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial
Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 3</U>. <U>Certain
Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective
date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Subsequent
Equity Sales</U>. If the Company or any Subsidiary thereof, as applicable, at any time while this Warrant is outstanding, shall sell,
enter into an agreement to sell or grant any option to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue
(or announce any offer, sale, grant or any option to purchase or other disposition) any Common Stock or Common Stock Equivalents, at an
effective price per share less than the Exercise Price then in effect (such lower price, the &ldquo;Base Share Price&rdquo; and such issuances
collectively, a &ldquo;<U>Dilutive Issuance</U>&rdquo;) (it being understood and agreed that if the holder of the Common Stock or Common
Stock Equivalents so issued shall at any time, whether by operation of purchase price adjustments, reset provisions, floating conversion,
exercise or exchange prices or otherwise, or due to warrants, options or rights per share which are issued in connection with such issuance,
be entitled to receive shares of Common Stock at an effective price per share that is less than the Exercise Price, such issuance shall
be deemed to have occurred for less than the Exercise Price on such date of the Dilutive Issuance at such effective price), then simultaneously
with the consummation (or, if earlier, the announcement) of each Dilutive Issuance the Exercise Price shall be reduced and only reduced
to equal the Base Share Price, <U>provided,</U> that if at any time the Base Share Price is less than the Floor Price (as defined below),
the Exercise Price shall be reduced to equal the Floor Price; <U>provided</U>, <U>further</U>, if one or more Dilutive Issuances occurred
prior to the Shareholder Approval being obtained and the reduction of the Exercise Price was limited by clause (i) of the definition of
Floor Price, once the Shareholder Approval is obtained, the Exercise Price will automatically be reduced to equal the greater of (i) lowest
Base Share Price with respect to any Dilutive Issuance that occurred prior to the Shareholder Approval being obtained, and (ii) the price
determined by reference to clause (ii) of the definition of Floor Price. As used herein, the &ldquo;<U>Floor Price</U>&rdquo; shall mean
(i) until the Shareholder Approval is obtained, $4.80 per share (subject to adjustment for reverse and forward stock splits, recapitalizations
and similar transactions following the date of the Purchase Agreement), and (ii) after the Shareholder Approval is obtained, $1.00 per
share (subject to adjustment for reverse and forward stock splits, recapitalizations and similar transactions following the date of the
Purchase Agreement). Notwithstanding the foregoing, no adjustments shall be made, paid or issued under this Section 3(b) in respect of
any issuance set forth in clause (a) (other than with respect to issuances to consultants), (b) or (c) of the definition of Exempt Issuance
(as defined in the Purchase Agreement). The Company shall notify the Holder, in writing, no later than the Trading Day following the issuance
or deemed issuance of any Common Stock or Common Stock Equivalents subject to this Section 3(b), indicating therein the applicable issuance
price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice, the &ldquo;Dilutive Issuance Notice&rdquo;).
For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this Section 3(b), upon the
occurrence of any Dilutive Issuance, the Holder is entitled to receive a number of Warrant Shares based upon the Base Share Price regardless
of whether the Holder accurately refers to the Base Share Price in the Notice of Exercise. If the Company enters into a Variable Rate
Transaction, the Company shall be deemed to have issued Common Stock or Common Stock Equivalents at the lowest possible price, conversion
price or exercise price at which such securities may be issued, converted or exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;Purchase Rights&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale
of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined
for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right to participate in any such
Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate
in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such
extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Pro Rata
Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;Distribution&rdquo;), at any time after the issuance
of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the
Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, that, to
the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial
Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial
ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be
held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one
or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company
or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv) the Company, directly
or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock
or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash
or property, or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement
or other business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement)
with another Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common
Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated
with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &ldquo;<U>Fundamental
Transaction</U>&rdquo;), then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant
Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option
of the Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the
&ldquo;<U>Alternate Consideration</U>&rdquo;) receivable as a result of such Fundamental Transaction by a holder of the number of shares
of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to any limitation
in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be
appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of
one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration
in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common
Stock are given any choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be
given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction.
Notwithstanding anything to the contrary, in the event of a Fundamental Transaction, the Company or any Successor Entity (as defined below)
shall, at the Holder&rsquo;s option, exercisable at any time concurrently with, or within 30 days after, the consummation of the Fundamental
Transaction (or, if later, the date of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from
the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised
portion of this Warrant on the date of the consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the
Fundamental Transaction is not within the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, Holder shall
only be entitled to receive from the Company or any Successor Entity the same type or form of consideration (and in the same proportion),
at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of
the Company in connection with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination
thereof, or whether the holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection
with the Fundamental Transaction; <U>provided</U>, <U>further</U>, that if holders of Common Stock of the Company are not offered or paid
any consideration in such Fundamental Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor
Entity (which Entity may be the Company following such Fundamental Transaction) in such Fundamental Transaction. &ldquo;<U>Black Scholes
Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function
on Bloomberg determined as of the day of consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A)
a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the time between the date of the public announcement
of the applicable contemplated Fundamental Transaction and the Termination Date, (B) an expected volatility equal to the greater of 100%
and the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the
Trading Day immediately following the public announcement of the applicable contemplated Fundamental Transaction, (C) the underlying price
per share used in such calculation shall be the greater of (i) the sum of the price per share being offered in cash, if any, plus the
value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii) the highest VWAP during the period
beginning on the Trading Day immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or
the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request pursuant
to this Section 3(e) and (D) a remaining option time equal to the time between the date of the public announcement of the applicable contemplated
Fundamental Transaction and the Termination Date and (E) a zero cost of borrow. The payment of the Black Scholes Value will be made by
wire transfer of immediately available funds (or such other consideration) within the later of (i) five Business Days of the Holder&rsquo;s
election and (ii) the date of consummation of the Fundamental Transaction. The Company shall cause any successor entity in a Fundamental
Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations
of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant
to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay)
prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security
of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable
for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common
Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior
to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock
(but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such
shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic
value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in
form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and
be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Warrant and the other Transaction
Documents referring to the &ldquo;Company&rdquo; shall refer instead to the Successor Entity), and may exercise every right and power
of the Company and shall assume all of the obligations of the Company under this Warrant and the other Transaction Documents with the
same effect as if such Successor Entity had been named as the Company herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing
on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Voluntary
Adjustment By Company</U>. Subject to the rules and regulations of the Trading Market, the Company may at any time during the term of
this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise Price to any amount and for any period
of time deemed appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 4</U>. <U>Transfer
of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance
with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">d) <U>Authorized
Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant. The Company further
covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the duty of issuing the
necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such reasonable action
as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation,
or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants that all Warrant Shares
which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase rights represented
by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable
and free from all taxes, liens and charges created by the Company in respect of the issue thereof (other than taxes in respect of any
transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results
in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and
expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder
in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered in
accordance with the notice provisions of the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>(Signature Page Follows)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">IN WITNESS WHEREOF, the Company
has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase"><B>Stran &amp; Company, Inc.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%">Name:&nbsp;</TD>
    <TD STYLE="width: 31%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">To: Stran
&amp; Company, Inc. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(2) Payment
shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ &nbsp;&nbsp;&nbsp;] in lawful money
of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in">[ &nbsp;&nbsp;&nbsp;] if permitted the
cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to exercise
this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set forth in
subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Shares shall be delivered to the following
DWAC Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(4) <U>Accredited Investor</U>.
The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: __________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Investing
Entity</I>: ____________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: ______________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: _______________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: ___________________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">ASSIGNMENT FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>(To assign the foregoing Warrant, execute this
form and supply required information. Do not use this form to purchase shares.)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">FOR VALUE RECEIVED, the foregoing Warrant and
all rights evidenced thereby are hereby assigned to</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 40%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Phone Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Email Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 42%"><FONT STYLE="font-size: 10pt">Dated: <U>_______________</U>&nbsp;<U>___</U>,&nbsp;<U>________</U></FONT></TD>
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature:&nbsp;<U>_______________________</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address:&nbsp;<U>________________________</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>6
<FILENAME>ea152147ex10-5_stranandco.htm
<DESCRIPTION>FORM OF REPRESENTATIVE WARRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.5</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIVE&rsquo;S
PURCHASE WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Stran
&amp; Company, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares:
    ______</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial Exercise
    Date: June 8, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date:
    December 8, 2021</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: left; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
<B>REPRESENTATIVE&rsquo;S PURCHASE WARRANT </B>(the &ldquo;Warrant&rdquo;) certifies that, for value received, _____________________
or its assigns (the &ldquo;Holder&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date referred to above as the Initial Exercise Date (the &ldquo;Initial Exercise Date&rdquo;)
and on or prior to 5:00 p.m. (New York City time) on December 8, 2026 (the &ldquo;Termination Date&rdquo;) but not thereafter, to subscribe
for and purchase from Stran &amp; Company, Inc., a Nevada corporation (the &ldquo;Company&rdquo;), up to ____ shares (as subject to adjustment
hereunder, the &ldquo;Warrant Shares&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall
be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>.&nbsp;<U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated December 8, 2021, among the Company and the purchasers
listed in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>.&nbsp;<U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed facsimile copy
or PDF copy submitted by email (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the &ldquo;Notice of Exercise&rdquo;).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank unless
the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to
the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full,
in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which
the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the
total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records
showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice
of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant, acknowledge
and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the
number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;<U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be $4.97, subject to adjustment hereunder (the &ldquo;<U>Exercise
Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;<U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in
Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the
Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;Bloomberg&rdquo;) as of the time of the Holder&rsquo;s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a
Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of &ldquo;regular trading
hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice of Exercise if
the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant to Section 2(a)
hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;VWAP&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on The New York Stock Exchange, the NYSE American or any tier of The Nasdaq Stock Market (each, a &ldquo;Trading Market&rdquo;),
the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which
the Common Stock are then listed or quoted as reported by Bloomberg (based on a trading day from 9:30 a.m. (New York City time) to 4:02
p.m. (New York City time)), (b) if the Common Stock is listed or quoted on the OTCQB or OTCQX (each as operated by OTC Markets Group,
Inc., or any successor market), the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on
OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on the OTCQB or OTCQX Markets and if prices
for the Common Stock are then reported in the OTC Pink Market published by OTC Markets Group Inc. (or a similar organization or agency
succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported, or (d) in all
other cases, the fair market value of a Common Stock as determined by an independent appraiser selected in good faith by the Board of
Directors of the Company and reasonably acceptable to the Holder, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant
to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics
                                            of Exercise</U>.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;<U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earliest
of (i) two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the
aggregate Exercise Price to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery
to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery Date</U>&rdquo;). Upon delivery of the Notice
of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate
Exercise Price (other than in the case of a cashless exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the
number of Trading Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails for
any reason to deliver to the Holder the Warrant Shares subject to a Notice of Exercise by the Warrant Share Delivery Date, the Company
shall pay to the Holder, in cash, as liquidated damages and not as a penalty, for each $1,000 of Warrant Shares subject to such exercise
(based on the VWAP of the Common Stock on the date of the applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per
Trading Day on the third Trading Day after the Warrant Share Delivery Date) for each Trading Day after such Warrant Share Delivery Date
until such Warrant Shares are delivered or Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant
in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares
of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately
preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing
herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.&nbsp;<U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other
incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and
such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>,
<U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;<U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below).&nbsp; For purposes of the foregoing sentence,
the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
Affiliates or Attribution Parties.&nbsp; Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial
ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section
13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the
extent that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is
exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to
any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations
promulgated thereunder. For purposes of this Section 2(e), in determining the number of outstanding shares of Common Stock, a Holder
may rely on the number of outstanding shares of Common Stock as reflected in (A) the Company&rsquo;s most recent periodic or annual report
filed with the Commission, as the case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice
by the Company or the Transfer Agent setting forth the number of shares of Common Stock outstanding.&nbsp; Upon the written or oral request
of a Holder, the Company shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock
then outstanding.&nbsp; In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since
the date as of which such number of outstanding shares of Common Stock was reported. The &ldquo;Beneficial Ownership Limitation&rdquo;
shall be 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to
the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall
continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61stday after such notice is delivered
to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>.&nbsp;<U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;<U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants, issues or sells
any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any
class of shares of Common Stock (the &ldquo;Purchase Rights&rdquo;), then the Holder will be entitled to acquire, upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares
of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale
of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be
determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&rsquo;s right to participate
in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled
to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase
Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its
right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution (other than cash) of stock or other securities, property or options by way of a dividend, spin off,
reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;Distribution&rdquo;), at any
time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to
the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided,
however, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding
the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in
the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution
shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder
exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;<U>Fundamental
Transaction</U>. Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly,
in one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company
(and all of its Subsidiaries, taken as a whole), directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance
or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect,
purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common
Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects
any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock
held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to,
such stock or share purchase agreement or other business combination) (each a &ldquo;Fundamental Transaction&rdquo;), then, upon any
subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the &ldquo;Alternate Consideration&rdquo;) receivable
as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is exercisable
immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this Warrant).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;Successor Entity&rdquo;) to assume in writing all of the
obligations of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in
form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so
that from and after the date of such Fundamental Transaction, the provisions of this Warrant referring to the &ldquo;Company&rdquo; shall
refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations
of the Company under this Warrant with the same effect as if such Successor Entity had been named as the Company herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)&nbsp;<U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock
for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange;
provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the
corporate action required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains,
material, non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice
with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period
commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise be expressly
set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>.&nbsp;<U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;<U>Transferability</U>.
Pursuant to FINRA Rule 5110(e)(1), neither this Warrant nor any Warrant Shares issued upon exercise of this Warrant shall be sold, transferred,
assigned, pledged or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result
in the effective economic disposition of the securities by any person for a period of 180 days immediately following the commencement
of sales of the offering pursuant to which this Warrant is being issued, except as permitted under FINRA Rule 5110(e)(2). Subject to
the foregoing restriction, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant
at the principal office of the Company or its designated agent, together with a written assignment of this Warrant substantially in the
form attached hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon
the making of such transfer. Upon such surrender and, if required, such payment, the Company shall execute and deliver a new Warrant
or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in such instrument
of assignment, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant
shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender
this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant
to the Company within three (3) Trading Days of the date on which the Holder delivers an assignment form to the Company assigning this
Warrant in full. This Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant
Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;<U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;<U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;<U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>.&nbsp;<U>Registration Rights</U>. The Holder shall be entitled to the registration rights provided to the purchasers pursuant to
that certain Registration Rights Agreement, dated December 8, 2021, among the Company and the purchasers signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
6</U>.&nbsp;<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)&nbsp;<U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)&nbsp;<U>Governing
Law; Venue</U>. This Warrant shall be deemed to have been executed and delivered in New York and both this Warrant and the transactions
contemplated hereby shall be governed as to validity, interpretation, construction, effect, and in all other respects by the laws of
the State of New York applicable to agreements wholly performed within the borders of such state and without regard to the conflicts
of laws principals thereof (other than Section 5-1401 of The New York General Obligations Law). Each of the Holder and the Company: (a)
agrees that any legal suit, action or proceeding arising out of or relating to this Warrant and/or the transactions contemplated hereby
shall be instituted exclusively in the Supreme Court of the State of New York, New York County, or in the United States District Court
for the Southern District of New York, (b) waives any objection which it may have or hereafter to the venue of any such suit, action
or proceeding, and (c) irrevocably consents to the jurisdiction of Supreme Court of the State of New York, New York County, or in the
United States District Court for the Southern District of New York in any such suit, action or proceeding. Each of the Holder and the
Company further agrees to accept and acknowledge service of any and all process which may be served in any such suit, action or proceeding
in the Supreme Court of the State of New York, New York County, or in the United States District Court for the Southern District of New
York and agrees that service of process upon the Company mailed by certified mail to the Company&rsquo;s address or delivered by Federal
Express via overnight delivery shall be deemed in every respect effective service of process upon the Company, in any such suit, action
or proceeding, and service of process upon the Holder mailed by certified mail to the Holder&rsquo;s address or delivered by Federal
Express via overnight delivery shall be deemed in every respect effective service process upon the Holder, in any such suit, action or
proceeding. THE HOLDER (ON BEHALF OF ITSELF, ITS SUBSIDIARIES AND, TO THE FULLEST EXTENT PERMITTED BY LAW, ON BEHALF OF ITS RESPECTIVE
EQUITY HOLDERS AND CREDITORS) HEREBY WAIVES ANY RIGHT HOLDER MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY CLAIM BASED UPON, ARISING
OUT OF OR IN CONNECTION WITH THIS WARRANT AND THE TRANSACTIONS CONTEMPLATED BY THIS WARRANT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries to be provided hereunder shall be made in accordance with Section 5.4 of the
Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Stran &amp;
    Company, Inc. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 31%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 2.5in"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 2.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:&nbsp;Stran
&amp; Company, Inc. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)&nbsp;The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)&nbsp;Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]
in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;&nbsp;]
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)&nbsp;Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _____________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _______________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
____________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 40%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 20%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify; width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">(Please Print)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Phone Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Email Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 10.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 42%"><FONT STYLE="font-size: 10pt">Dated: <U>_______________</U>&nbsp;<U>___</U>,&nbsp;<U>________</U></FONT></TD>
    <TD STYLE="width: 18%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Signature:&nbsp;<U>_______________________</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Holder&rsquo;s Address:&nbsp;<U>________________________</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ea152147ex99-1_stranandco.htm
<DESCRIPTION>PRESS RELEASE DATED DECEMBER 8, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stran
&amp; Company, Inc. Announces Pricing of a $21.7 Million Private Placement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUINCY,
Mass., December 8, 2021 (GLOBE NEWSWIRE) -- Stran &amp; Company, Inc. (&quot;Stran&quot; or the &quot;Company&quot;) (NASDAQ: STRN) (NASDAQ:
STRNW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today
announced that it entered into a securities purchase agreement with certain institutional investors to purchase approximately $21.7 million
worth of its common stock and warrants in a private placement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the securities purchase agreement, Stran has agreed to sell 4,371,926 shares of its common stock and warrants to purchase
5,464,907 shares of common stock. The warrants will be exercisable immediately upon the date of issuance and have an exercise price of
$4.97 per share. The warrants will expire five years from the date of issuance. The purchase price for one share of common stock and
one and one-fourth corresponding warrant will be $4.97. The warrants are subject to standard anti-dilution provisions and with respect
to any subsequent equity sale that is deemed a dilutive issuance, the warrants will be subject to a floor price of $4.80 per share before
shareholder approval is obtained. After shareholder approval is obtained, the floor price will be reduced to $1.00 per share. The gross
proceeds to the Company from the private placement are estimated to be approximately $21.7 million before deducting the placement agent's
fees and other estimated offering expenses. The offering is expected to close on or about December 10, 2021, subject to the satisfaction
of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use the net proceeds from the private placement for acquisitions and partnerships, investments in technology and expanding
corporate infrastructure, expansion of its sales team and marketing efforts and for general working capital and administrative purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EF
Hutton, division of Benchmark Investments, LLC, is acting as exclusive placement agent for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock and warrants described above have not been registered under the Securities Act of 1933, as amended, and may not
be offered or sold in the United States absent registration with the Securities and Exchange Commission (SEC) or an applicable exemption
from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement
with the investors, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares
of common stock and the shares issuable upon exercise of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor
shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Stran &amp; Company, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the past 26 years, Stran has grown to become a leader in the promotional products industry, specializing in complex marketing programs
to help recognize the value of promotional products, branded merchandise and loyalty incentive programs as a tool to drive awareness,
build brands and impact sales. Stran is the chosen partner of many Fortune 500 companies, across a variety of industries, to execute
their promotional marketing, loyalty and incentive, sponsorship activation, recruitment, retention, and wellness campaigns. Stran provides
world-class customer service and utilizes cutting-edge technology, including efficient ordering and logistics technology to provide order
processing, warehousing and fulfillment functions. The Company&rsquo;s mission is to develop long-term relationships with its clients,
enabling them to connect with both their customers and employees in order to build lasting brand loyalty. Additional information about
the Company is available at: www.stran.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking statements&rdquo; that are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo;
&ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;target,&rdquo; &ldquo;aim,&rdquo; &ldquo;should,&rdquo;
&quot;will&rdquo; &ldquo;would,&rdquo; or the negative of these words or other similar expressions, although not all forward-looking
statements contain these words. Forward-looking statements are based on the Company&rsquo;s current expectations and are subject to inherent
uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions
as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section
titled &ldquo;Risk Factors&rdquo; in the final prospectus related to the public offering filed with the SEC and other reports filed with
the SEC thereafter. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no
duty to update such information except as required under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crescendo
Communications, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
(212) 671-1021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRN@crescendo-ir.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Press
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howie
Turkenkopf</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">press@stran.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>8
<FILENAME>ea152147ex99-2_stranandco.htm
<DESCRIPTION>PRESS RELEASE DATED DECEMBER 10, 2021
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><IMG SRC="ex99-2_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stran
&amp; Company, Inc. Announces Closing of a $21.7 Million Private Placement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quincy,
Mass, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Stran &amp; Company, Inc. (&quot;Stran&quot; or the &quot;Company&quot;) (NASDAQ: STRN) (NASDAQ:
STRNW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today
announced the closing of its previously announced private placement of common stock and warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the securities purchase agreement, Stran sold 4,371,926 shares of its common stock and warrants to purchase up to 5,464,903
shares of common stock. The warrants will be exercisable immediately upon the date of issuance and have an exercise price of $4.97 per
share. The warrants will expire five years from the date of issuance. The purchase price for one share of common stock and one and one-fourth
corresponding warrant will be $4.97. The warrants are subject to standard anti-dilution provisions and with respect to any subsequent
equity sale that is deemed a dilutive issuance, the warrants will be subject to a floor price of $4.80 per share before shareholder approval
is obtained. After shareholder approval is obtained, the floor price will be reduced to $1.00 per share. The gross proceeds to the Company
from the private placement are estimated to be approximately $21.7 million before deducting the placement agent's fees and other estimated
offering expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company intends to use the net proceeds from the private placement for acquisitions and partnerships, investments in technology and expanding
corporate infrastructure, expansion of its sales team and marketing efforts and for general working capital and administrative purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EF
Hutton, division of Benchmark Investments, LLC, acted as exclusive placement agent for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock and warrants described above have not been registered under the Securities Act of 1933, as amended, and may not
be offered or sold in the United States absent registration with the Securities and Exchange Commission (SEC) or an applicable exemption
from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement
with the investors, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares
of common stock and the shares issuable upon exercise of the warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor
shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Stran &amp; Company, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
the past 26 years, Stran has grown to become a leader in the promotional products industry, specializing in complex marketing programs
to help recognize the value of promotional products, branded merchandise and loyalty incentive programs as a tool to drive awareness,
build brands and impact sales. Stran is the chosen partner of many Fortune 500 companies, across a variety of industries, to execute
their promotional marketing, loyalty and incentive, sponsorship activation, recruitment, retention, and wellness campaigns. Stran provides
world-class customer service and utilizes cutting-edge technology, including efficient ordering and logistics technology to provide order
processing, warehousing and fulfillment functions. The Company&rsquo;s mission is to develop long-term relationships with its clients,
enabling them to connect with both their customers and employees in order to build lasting brand loyalty. Additional information about
the Company is available at: www.stran.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains &ldquo;forward-looking statements&rdquo; that are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of words such as &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;contemplate,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;may,&rdquo; &ldquo;might,&rdquo;
&ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;target,&rdquo; &ldquo;aim,&rdquo; &ldquo;should,&rdquo;
&quot;will&rdquo; &ldquo;would,&rdquo; or the negative of these words or other similar expressions, although not all forward-looking
statements contain these words. Forward-looking statements are based on the Company&rsquo;s current expectations and are subject to inherent
uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions
as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section
titled &ldquo;Risk Factors&rdquo; in the final prospectus related to the Company&rsquo;s initial public offering filed with the SEC and
other reports filed with the SEC thereafter. Forward-looking statements contained in this announcement are made as of this date, and
the Company undertakes no duty to update such information except as required under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Crescendo
Communications, LLC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel:
(212) 671-1021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STRN@crescendo-ir.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Press
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howie
Turkenkopf</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">press@stran.com</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ .8# 2(  A$! Q$!_\0
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MO#H/B#3K+48%LM*U*P>UN #];JXSXC:GXQT7P!XUU?X>:!9>*_'FE^%=>O\
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M_:(T[Q!KS?L1Z)\;H/@5/H<%EIS>$[[0TTF66^\02;K+^U6\4W6G)=_$>PU
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M?NF4\W.AZY:7^F2.0OG"V6X51',A/^?%<:T[.[%B%' )Z'L"/K[9/-?TQ?\
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MVU#3=%\-:-XBU2PL? Y\26FI7IU3Q-J4UWKNA1:E<7GC;39UTBTL-1\^YM?
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M\_B]0!Y!J%MXD_X)%?M1+K%A%JVL?L0_'_5A#?640N;]OAYK,2,XBC7]X_\
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M^XU+P[K44D^F7TVE7]OJ>GM<P1R1><+74+2VNHT=C&984+JP&*\4T?\ 8?\
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M-\?/&U8R5FI13PU50=TG>E"G)/X9QW7X+GGT=O&CCY3H^(?TE\]EE=;2OD?
MG"N'X5RRI3EI.C.-/-L/5KTVFXI8S$8J+B_WE.IJG_#O\//^"1W[>OQ,EC:+
MX++\/M.N'5Y-4^)_B70_"B1&9COGGTBVN-8\3LZDLTB#0VF;OR5S^G/P,_X-
M\='M[FSU;]I3XY7FO11-')<>"/A#IKZ!83[5!:WO/''B&.ZUF:!FW)(-+\/Z
M)<%.8KV)L&OZ4:*]3-/'/CS'TI4,%BL%D5&2<;Y5A(K%*+5K1QN-EBZT'9VY
MJ-*E);QE%I->YP7]#;P7X1J4\3B\!G'&&,IR4_:<3YG*K@I33YN:65993R[!
M5%=)N.)K8F+VG&:NGXO\#/V>/@M^S7X-B\!?!#X>>'_A_P"'%>.>\AT>V9M1
MUJ]C0H-2\1:W>27.L^(-3*LP-_K%]>W*HQBCD2(+&/:***_),3BL3C<16Q>,
MQ%?%XK$3E5KXG$UJN(Q%:I+XIU:U:=2K4F]+RG-NR27+%1C'^HL%@<%EN$P^
M R[!X7 8'"4H4,+@L%AZ&$PF&HP5H4J&&P]*C1HTXK:-.G%7;;YI2E*17S_^
MTE\(-1^.'@#1O!%A?PZ;'%\3OA7XLU>Z;4M5T:^30?!?CO0_$VL?V%J^BHVH
MZ;XD%CILK^'[V!X5@U9+5YYXH!(U?0%%8'4?*R_LF^$M2TSXGP>.O'GQ-^)/
MB'XJ?#Z[^%&K>-/%NLZ$GB#0/AW=+=EO#7A"#P]X;T+P[HB37-VVJ:IJ2Z%<
M:KKVKPVE[K5Y?)8:?;VG??$KX':%\1/^$'U.V\2>+O ?C7X:R7C>!_B!X+O[
M"V\2:/;:I80:;K>CWD&LZ9K/A_Q!X>\06MG8_P!M:'KVBZA87-SIVFZA!':Z
MEIUC>6_M=% 'SCH?[,'@#1M+\,VLNK>,M;UK0OB_;?'35O&.NZW#?>*?''Q'
MMM'O_#\>J>+KT6$5G/IT6BWL.DV6AZ-8:+I.DZ5I.C:;I%K8V-@L#ZOB3]G;
MP+XIT+XY^']1O/$L=E^T#J-EJ7C=[34[>*XM)[#PKX;\(0KX<D>PD738FTOP
MMITDBSI?,U[)=S*RI*D47O-% 'S+X[_9@T#QCXH\7>)M%^(OQ4^&8^)>GZ?I
MGQ4T7X=^(M.TG2OB!#IFGIHUK?WIU/0]8U+PUXD;08;;P[=^*O!&H>&O$%YH
M5I96=Q?O-IVFW=ET,W[/?A*S\9?"WQGX,UGQ-\.Y_A7X23X=Z?H/A&XTF/PU
MXA^&\-QI=Y:^!_$.F:UH^LL=*L;S1=/FL;[1;G1M=MT6ZMQJK07<J5[S10!\
MSZE^RQX%N- TG3=$\0>./"7B+PQ\2O'?Q7\'?$#P_K%C'XO\+>*OB/K>NZUX
MMMK.6_TF^T74O"^KCQ%J.D7_ (6U_1M6TF^T?[+%=PRW]C9:C;RZ3^R[X%L=
M*@M]3U[QMXG\23?%KP?\:_$OCW7]9L[CQ;XQ\<^!KC3G\.?VY/:Z7::5;^&]
M,L=)T[0]/\+Z#I6C:/IFB6D=IIUO:S27-U/])T4 ?._CO]F?P'X^U/QWKU_J
M?BS2?$/C?4?A3KT>N:)JMK;WOA+Q/\%KZ_U/P#XD\*QW6FWEG!J%A?ZA+/?6
M^KVVL:5JBHEO=Z>UNTT4F%'^RAX1O-/^)$/BOQS\2_&NL?%B7X6W'C/Q'KVM
MZ0FH2S?"+7CXA\+1Z%8Z5H.G:'X;TYKYF74-+TK2H;*XBDGE6.._NKN^G^I:
M* .0\=>$F\;^&KSP]'XH\6^#)[F:RN;;Q+X'U:/1O$>F7-A>07L$EI=7%IJ%
MC-!+) (+[3]3T[4-,U&REGLKZSN+>9T/@2?LC^!Y/">M:/J'BWQ_>>--<^)E
MK\9I_B[;:IHVA?$#3_B?8:+9>&;#Q5HO_"/Z#IGA/33!X7L(_#-UHZ^%Y=$U
MO0KC4K+Q%8:P=4U"6Y^K** /E^']E/P5=>%_'^B^*_%?C[QOXC^*.K>"]5\<
M_$3Q!JVEKXNU1/A[KEAK_A#0]/32M%T[PWX>\+Z)>6,HM- T+0+&S_XFNM7D
M_G:KJMYJ,F9\2OV0?!GQ*U;XEW%QX_\ BKX4\,_&:RM(?BKX#\'>)-,TOPOX
MQU33M$M/#ECXAE:ZT#4->T757T33]+TS6H_#VM:7I?B:STC2X-?T[4(X;E;S
MZSHH \;?X,Z=%\7;#XP:/XN\9:#JG_"):7X+\4>&--O-'D\(^.=&\.S:]=>%
MV\16&HZ)?:A;ZAX>O/$VLSV=]X=U30I;E;L6VI?;;6&&%//%_9,\%Z5X8^&.
MC>"/&/Q"\ >)/A!8^(-(\$_$/P[JVD2^+$\/^*[Y=1\1^&?$4&M:%JGA?Q3X
M=U:^@TZ^DTO6_#MTEIJ&CZ3J6FR65_:?:)/J>B@#YZ\,_LT?#_PM9> X+.^\
M67^H^!OB;K?Q@F\1ZSK::CXB\;_$/Q)X;\1^%M;\0>.=0DLD75I;S3/$MU''
M:V%OI5EIT>GZ+8:5;6.D:7:Z<M[5_@/I]S<>.M4\,_$#XD> /$/CWQ]I'Q'U
M+7O".LZ3%<6VN:+X+T;P+;:<FG:QH6KZ+J7ABZTC0K&?4= UW3=5MKG4@]]'
M);SI:M;>[T4 >9?"3X5>'?@YX0'A#PY<ZIJ$=QKGB/Q5K6LZU+:2:KK_ (H\
L7:S>>(/$FN7T>FV6F:1:3:GJU]<W'V'1M+TS2K.-DM[&PMXD"DKTVB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ex99-2_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  [ .(# 2(  A$! Q$!_\0
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M)=/U$V\K6\(!_1U7*^.O^1(\9?\ 8J^(?_31>5U5<KXZ_P"1(\9?]BKXA_\
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MJBPC=+<2,Y8D830?V3/V7O#&/["_9X^"^GLH 66/X:^$99EP01MGN-)FF!R
M<AP<CDU[V7UN&Z$*<LQP>;X^NM:E*CB\)@L->[]V,E3K8B4;63DW"3=[)*Q^
M)\999](7-LTQM#@KBKPJX.X?=3DP&-S+AKBGBSB:5#V=-.OB:5;'99P_A\3*
MI[9PHT*.*HTH*DI5JLW4:_G:^*__  7 _:2\?-<Z-\#/AOX2^&\=PS1VVH?9
MK_XI^,41E*HT"/9Z?X<@G)(8++X?U15/RJ7X8_GYXJ^%G_!1#]L#5XM9\2^
M?VE?C'/)*&M;SQ5H/B*P\+:?))RO]G1:_%H7@[18N@S806D2(!R%%?W%Z-X3
M\*^'(UA\/>&?#^@Q)PD6C:-IVEQH,8PJ6-M J\ #@#@8KH*^]RGQ,ROAOWN'
M>",HPV(2M'&8[$UL7BMK7=:-#V_>ZAB*,7=IZ'XIG'T4>.>/JJGXK_2*XVXG
MPCGSSR3(\HP/#V2)I\RC2R]8[ZE%1=N6=7+L94CRIQDGJ?QK_"W_ ((:?MI>
M/Y;:X\=3?#GX+:5*JR32^)?$7_"6^(4B<#Y8M \&I?6#3HO6&\\2V'S85F7G
M'["?LU_\$._V5?@U?:;XG^*UUK7[1?B_3Y8;J"'QI;6NC_#JTO(2KQRP?#_3
M)9[?5!%(N5C\5ZMXBM7X8VB-@#]I**YL\\9./L\HU,*\W64X.K%PGA\DHK+Y
M3A)-.$\9&=7,)1:;4E'%X?F3:;LVC]/X%^BSX,\!5*&*P?#<\_S'#RA4I9AQ
M7BY9W*G5@XN-6CE]2EA\GI3C**E%_P!G8GDDDXZI-5K.SM-.M+73]/M;:QL+
M&W@L[*RLX(K:TL[2VC6&VM;6V@5(;>WMX42*"")$BBC18XU55 %FBBORYMMM
MMMMMMMMMMMMMMMMMMMMMMMMMMMMM_P!#I**48I1C%)1C%)))))))))))))))
M))))))(KY \3_LU>)?%7QV^(WQ6M/BIXQ^&<'BGX??#;P1I&H?#/5["U\036
MGAJ]\?7/B:R\1:7XH\->(_"TL4O_  DNES^%M=M+(^)-$O(]3>TO[."9X+KZ
M_HI#/#?!?[//PY^'VJ?#/4O"EOK&G+\*/ 7BSX>>&+%]6FO;6XTGQMJ_AK7?
M$6J:_-?)<:CK7B/4-7\,6NHW&M7=^;BZO;_5[N\%S<7OFQ\#XB_9"\$^(=5\
M71#QM\3=&^&_Q%\2R>+_ (C?!C1?$.GVOPZ\9:_=S0W.N27:RZ+/XLT;2/&%
MS#]I\<>'/#/BC1=!\5W$U[+J=@YU76!J/UA10!X;KG[/O@;7K3X\65W<:_!;
M_M#Z'9>'_&ZV6H6]O]@L-/\ !$?@&W_X1@?8772I1HD:R,TZWR&_S.(UBQ +
MVN? GX?^)]>&N>([.]UN&3X/^(O@=J&@ZA=))H&K>!/%5_HE_K5OJ5G'!'/-
MJ%R=!M+87D5W"([6:Z5(1+(DL7LE% 'S1X!_9CT+P9XH\)^*-;^(WQ4^*$OP
MWT[4=)^%VF?$?Q#IFK:=X!M=4L3I-Y>V7]EZ'HU]XC\2-H;S>'X?%GC6\\2>
M(K?0[F\LH-0234=4N;Z+1_V6/!^D^#M8^';^,/B#J?@2Z^)/A[XF^&_#6HZK
MHKP>!=2\/_$&'XGQZ%X:U&W\/V^KR^&[_P 71-/=V?B&_P!=O8].D_LNQU&T
MMXXBOTY10!\K>+_V3?"/BK6?',UMX\^*'A'P7\6-035/BW\+_"7B+3M-\%?$
M&_>RMM,U:XO#/HEYXF\-'Q;I5G;:5XXC\$^(O#<?BRQB/]IHUY<WUY=^F6_P
M4\%VFK?$_5K,:G9M\5_!WA;P-X@L+2YMX-,TW0?"&C>(="T>/P[:1VBC2YDT
M_P 27T<K,US"6ALC%#$L#))Z[10!\F7/[(?A*'R8O"OQ#^*G@2SOOA9X/^#O
MC6V\*:[HMO-X\\&^ ='U+1/";ZOJ6H>'=1U/1/$6EV&KZG!_PD/@VZ\-W\\-
M[,DK%X[.6U]/\"_ [P=\/==\/>(-!N-<>]\,_!OP=\#M.BO[^&YM3X.\#WEW
M>Z/<7$26D+RZY)+>RK>WXE2&>-8U2TB*EF]DHH ^>OC'^SSIWQH;4['7?B1\
M3=%\(>)] B\*^-_A_H6K:#)X.\7>'TN+BXGMI[#7_#FN7OA[4;];AK*_U[PA
MJ'A_69[!8H_MB7-M97=KC>-OV6_#OBKQ'XH\0:!\1?BK\,(OB'I.E:)\3]#^
M'?B33],TKQ[9Z+IL>B6%Y>MJVBZUJ?ASQ&/#T%KX;NO%?@K4?#?B*]T&TLK.
MYU"2?3M,N[+Z>HH \"OOV:/A-?MJUM+HD\7AW6/@9:_L[3^$+2[:T\.6_P ,
MK*XU.:VTZPMX$2_L[^&+59[.+48M0$T-M%;&)8[F$7#8OP^_9DT7P5XOTSQU
MKGQ+^*_Q1\2Z)X!USX7Z1>?$7Q!HU]!9^!]<O_#^H3::UCH'AWP]9W6J"7PU
MIPNO$US#)XAU<F9M9U"^VVBVOTO10!\S>%?V7?"WAKP?\.? USXW^(OBCP_\
M(OB%H'C[X;Q>(M5T.:[\-0^%=)O]$\->#/MVG>'=.N-6\*Z1IVHW,$(UE[[7
M[@" W>NS^2N<?4OV0/ VI:CK-DWC/XE6OPJ\2>,W^(7B+X$VNO::OPOU?Q7<
MZPGB+4WEAET.;Q99^&=>\2"3Q)XA\#:9XIL?"&LZW<WD]WH[6=_J%A=_6-%
M'B>L_ 7P9KFB?'C0+R\\0K9?M#FZ;QR\&HVZ7%D;SP#HGPYE_P"$;D:Q==-"
MZ%H-E/&+A+_;J3W%R<QR+;IS/C;]FG1/'^MV<_B+XB?$VZ\%1:SX(\0WWPLD
MU?0;CP/?:S\.[C2K_P +W=JUYX<N?%7AN*/5-&L-4U>R\+>)M%LM9OH6DNX-
/MUJ"7GTE10 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>strn-20211208.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qA5s7xRiXgen8uKa3EsWamOKaPtzplyGZlBtmdzbXla3yUoVV5oHynYZ1uWQcQD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:STRN="http://stran.com/20211208" elementFormDefault="qualified" targetNamespace="http://stran.com/20211208">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://stran.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="strn-20211208_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="strn-20211208_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="strn-20211208_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="STRN_CommonStockParValue0.0001PerShareMember" name="CommonStockParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" name="WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>strn-20211208_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://stran.com/role/Cover" xlink:href="strn-20211208.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://stran.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="strn-20211208.xsd#STRN_CommonStockParValue0.0001PerShareMember" xlink:label="loc_STRNCommonStockParValue0.0001PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_STRNCommonStockParValue0.0001PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="strn-20211208.xsd#STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" xlink:label="loc_STRNWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_STRNWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>strn-20211208_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="strn-20211208.xsd#STRN_CommonStockParValue0.0001PerShareMember" xlink:label="STRN_CommonStockParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STRN_CommonStockParValue0.0001PerShareMember" xlink:to="STRN_CommonStockParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STRN_CommonStockParValue0.0001PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="strn-20211208.xsd#STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" xlink:label="STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" xlink:to="STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member_lbl" xml:lang="en-US">Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $5.1875</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>strn-20211208_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.10c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://stran.com/role/Cover" xlink:href="strn-20211208.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://stran.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="strn-20211208.xsd#STRN_CommonStockParValue0.0001PerShareMember" xlink:label="loc_STRNCommonStockParValue0.0001PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_STRNCommonStockParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="strn-20211208.xsd#STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" xlink:label="loc_STRNWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_STRNWarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>ea152147-8k_stranandcom_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:STRN="http://stran.com/20211208"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="strn-20211208.xsd" xlink:type="simple"/>
    <context id="From2021-12-08to2021-12-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872525</identifier>
        </entity>
        <period>
            <startDate>2021-12-08</startDate>
            <endDate>2021-12-08</endDate>
        </period>
    </context>
    <context id="From2021-12-082021-12-08_custom_CommonStockParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872525</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">STRN:CommonStockParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-08</startDate>
            <endDate>2021-12-08</endDate>
        </period>
    </context>
    <context id="From2021-12-082021-12-08_custom_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001872525</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">STRN:WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-08</startDate>
            <endDate>2021-12-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-12-08to2021-12-08">0001872525</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-12-08to2021-12-08">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-12-08to2021-12-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-12-08to2021-12-08">2021-12-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-12-08to2021-12-08">STRAN     &amp; COMPANY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-12-08to2021-12-08">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-12-08to2021-12-08">001-41038</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-12-08to2021-12-08">04-3297200</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-12-08to2021-12-08">2     Heritage Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-12-08to2021-12-08">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-12-08to2021-12-08">Quincy</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-12-08to2021-12-08">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-12-08to2021-12-08">02171</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-12-08to2021-12-08">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-12-08to2021-12-08">833-3309</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-12-08to2021-12-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-12-08to2021-12-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-12-08to2021-12-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-12-08to2021-12-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-12-082021-12-08_custom_CommonStockParValue0.0001PerShareMember">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-12-082021-12-08_custom_CommonStockParValue0.0001PerShareMember">STRN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-12-082021-12-08_custom_CommonStockParValue0.0001PerShareMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="From2021-12-082021-12-08_custom_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member">Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $5.1875</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-12-082021-12-08_custom_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member">STRNW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-12-082021-12-08_custom_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-12-08to2021-12-08">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2021-12-08to2021-12-08">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139773868152840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  08,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STRAN
    & COMPANY, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001872525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3297200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2
    Heritage Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Quincy<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">833-3309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=STRN_CommonStockParValue0.0001PerShareMember', window );">Common Stock, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">STRN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member', window );">Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $5.1875</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $5.1875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">STRNW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=STRN_CommonStockParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=STRN_CommonStockParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MR#@_##F#U&8;P/VEE.;UQ&Y#%;N(@S\!4$L#!!0    ( +DQC5/@]#J)J@(
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( +DQC5.+P?!0V 0  %$4   8
M          " @0P(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " "Y,8U3X/0ZB:H"   P#   #0              @ $:#0  >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( +DQC5.7BKL<P    !,"   +
M  "  >\/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( +DQC5.JQ"(6,P$  "("
M   /              "  =@0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" "Y,8U3)!Z;HJT   #X 0  &@              @ $X$@  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "Y,8U399!YDAD!  #/ P
M$P              @ $=$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
.."0 ) #X"  !G%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea152147-8k_stranandcom.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://stran.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ea152147-8k_stranandcom.htm">ea152147-8k_stranandcom.htm</File>
    <File>ea152147ex10-1_stranandco.htm</File>
    <File>ea152147ex10-2_stranandco.htm</File>
    <File>ea152147ex10-3_stranandco.htm</File>
    <File>ea152147ex10-4_stranandco.htm</File>
    <File>ea152147ex10-5_stranandco.htm</File>
    <File>ea152147ex99-1_stranandco.htm</File>
    <File>ea152147ex99-2_stranandco.htm</File>
    <File>strn-20211208.xsd</File>
    <File>strn-20211208_def.xml</File>
    <File>strn-20211208_lab.xml</File>
    <File>strn-20211208_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>22
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea152147-8k_stranandcom.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 3,
   "dts": {
    "definitionLink": {
     "local": [
      "strn-20211208_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ea152147-8k_stranandcom.htm"
     ]
    },
    "labelLink": {
     "local": [
      "strn-20211208_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "strn-20211208_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "strn-20211208.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 65,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 2,
   "memberStandard": 0,
   "nsprefix": "STRN",
   "nsuri": "http://stran.com/20211208",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea152147-8k_stranandcom.htm",
      "contextRef": "From2021-12-08to2021-12-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://stran.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea152147-8k_stranandcom.htm",
      "contextRef": "From2021-12-08to2021-12-08",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 2,
   "tag": {
    "STRN_CommonStockParValue0.0001PerShareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.0001 per share"
       }
      }
     },
     "localname": "CommonStockParValue0.0001PerShareMember",
     "nsuri": "http://stran.com/20211208",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "STRN_WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $5.1875"
       }
      }
     },
     "localname": "WarrantsEachWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf5.1875Member",
     "nsuri": "http://stran.com/20211208",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://stran.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>23
<FILENAME>0001213900-21-064831-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-21-064831-xbrl.zip
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M1*A"&D'["K17QV$4%'><*I5@9G0T-)P?0)]\@T*6-"+#<QM8J:3QCY :"L[
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MBCQ:%SIWDX2A!0J0)WETGEYEL"B<JT9^"LW[-:P/008+-&Q11J;Z7%TD[[7
M4D]F4XO"7*"1S5[.SV("R4<&C #;) #&*$IT].@1!:_@U(%9/7R-VF6<B$(6
M':?[+<4Z5"G/^#5"T_!!GB7@SK.F)O^!I3X\8I9G<[@*$S%Y+AS&;4)8^&!\
M)WWX39F#+<?C!?5>/2B7#P@!M(@SSLY\VI(;&*/;PBK![0I40G52;9U^$GP1
MES=25)]7+U&+#BZ5"86'MZ9816L1N:BBW!IM&G&.X&>3Q8YK-K08"<%I*\:O
M*+>KLKN))RY(:#N:NI&T,MH^:$IID+K 8J;1EO4J76///%_P"[#0X5<XK[?P
MV";%\8$%EY/+-AZ5:S@1$F'%9R6YO#@,ML"W7R4+VOK!7>^=.CM=]$L_8>RQ
MZ',I]()*#;<J[D*&D\'%:6C+@J]9EP78_)A--4_7#9G_K;?<"THK*.MY5=Z.
M1Z1"NF+R E9X%;U$@?:<,.*+Y 9S=*)G2?&^9<S#EC@^.HQ.ZSK]#1. TQ14
M--T@CGXZB0Z/OOWZ<#_WO7/?S;6V:HHNXXP_4CN4_D9Y! B35QG*\K)C6> Q
M)/QF58HX=6(-_^"'L^G IF*/31&<3#Z*(78OP=!%N@9IW/1A];77(\$C)6**
MH0061)1NYN,2X/)C6@6&,LE%=-FY^QVT"Q1__"1Z0\M0?X=#$?WR)/HG0GWP
M]1^%U.\^+WU9ISNDAL+#S#3H!#R)+K=K>,^3*IEE\R?1ZV25\B2]+O'5CP/$
M7G^%W^RC"?^)6]X(34JVQLW<->T_)=6NW@>9@VD6_!2TTWQ +QG;U 5IT$@%
M<^_HVX>/*/T-CAT\8<&N.GDAA#'A7V %;_)$(\2N$"/R=1C[!0D6!$WB\>BL
M1H4\'W!I,_D6%P&=V%K<GV6 9!,6OG8!<DT7@H&S+<<)04/Y<O =Z>9ZDS=4
M,M'Z^O:ZI,0:<J_RNARX:>@C;34\I2.+0.^#8[U!4WX!'Z5<>4'G5U+,P6=$
M&P>F^1?.*I*!4#*4O!/,#5:HN4$^TVS %_[MJIY[F)\E%$!#;XBF-;B[>YWQ
M"#PO\#:R^KIGI/Q!6MV0H5SAF:B\U2,3]\2YL3$[6&0XP?*MI79*%Y<6S2Z
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M\PS'AO_X/]UN0':>6S,,X_B\4XSOW!I/4@<N%-(,]FP:L/5XW/WSW;(0VX]
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M,.<#9S9=]-%6=F+_L5#=]E!E]),-44)O([&[E\KT:"RB%M(T'EF>*#\R4]E
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M1#P*T]8B[BW=I^26?/_RS>M+?3I=18HFSXKT0=UL<[#.%B6X/BE87CL)5"?
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MGF]E$O6L ;_W06=OYJZ3'@T==-X8-/I>'35+]49+A'@ER8Q?M ZE!'M3F*.
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M>1;9Z^I-:T/WD;Z9H03%&,PN99_A 6 #&(T+E+J_GF;#BXH !U:RL"V%&#W
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M@-K%EB E?XIHE5(92N1E&O68E0E^\DS89*"1SPG*.11Z0XK=2%A %$<\DV[
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MRY?[:LN^TS[KWJG*2@7S>IW'";UQ/)I>A--3<9&JM4RALS[YSGL\@A?%C5N
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M1'"IKLLV3]5E#%>(9EU> SG!U8G;YK*$V<(Z2S7+<"8^G>(OX#]V!OR!*F?
MY&*Z,)W[A\,@<6AZSML*^%D"/P&FI\,CP.,!;F@9G]G9\2@MDY88%A(8R#LX
M%/PNU3GL4@5_A:=CC\3MU[K+;5^.UQ]82PJ;&*E9V^".JCQ;9/BRIHQX(F9
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MW_9V=Z/=W5W0T8Y\JWW09&+SG2(_ON,%78;M8A$[UV+@3NZ&L3J7T9Z&>/:
M.6*4(\'00]19]* :L&7W7_R5M.&\O!B(Z%VV8!'PMT>TU$FP8T,\(]@[L>$[
M;.C0O-WP%[N,M*M(X+^%33I] C3:;.Y\U45IY24^#GL;[/"Y;#Q-![W,=_CV
M&EOBP<XW_^?')Z>'KT\/SPZ/S\F:. -+XOA _6MZ>CH]/C\Z/%,G+]3YSX<*
M38[I\:]P+GB)9=,KC2YW&-MC?Z)S4"2J*2\TW2SKI#$:)=Q4C!VTI 04])7[
M2-7)I4[1DP.R8@EDP)X<.,FF!"$< [ONJ-!]?4'DVF" (T*"P.%@%*#4LEJ6
M%<U*@@\SB9V@D4Y!%V0Y%Y<@S=N<XBIUX_V<HV(8U8VM=NHHT[_DD7DI+0$C
M/?1DP2XF^/V@@-U1P#?B-,W8[UYRL S-[8N2R-G?"'LBP6'4=H,Z]Q ]77<X
MY0&MMZUL$NP0T(?"<QR/2!V))"Q)0L&/2Y*7!.,J99=5DY O4>\BO[H(,>2I
M@_&D)S %FD,P"$YCIC5P&R#TE7GU?R3<&,0>_0BK1(PBC--G_+6)'+DP LR&
M5$S4CD!M+&":B1:[E3A\E<9(VG0K<=[D]GR"_O@4)RL[YJ)97@1T-1#:,EK/
MD)AJW 6LR8&M%\O<WAZX"WY<;)YG22/B "X$4'*;-QS"0#<3,YZM57"@*-AU
M!320)7+IW)7.F-//5MMY?$V1'Q;TP"0J"J#:8"]\M?6?B;*^#X[3PRG;D*<E
M( I\\M;2V/(3\;7C=F(:AY;OX[K6I&VK&0C6NVZG3M$Y[/BX\3F1+V"(7W?8
M$;"TN")B#A(@*#37UAC7<"KV;80%?#%^BS$(7P:Q^WJ>Y?".NL<6B"U;7<3S
M,%!0[!U037'!"2U@/)'F"<?:5)1W@-<4-)Z$R15> M< ]A,TDIB"66'\E;*K
M*'B)[P:%"P<AJ6(N<.P&F&,,$VD7-%Z*HN+OZ,'P)Z!.P0:A^8)!470.XZ\7
ML MLCYGA9:$-BZ_(VLHY\D-S;Y.L@KN!(2ET'G*8R-X%H'E4JW"8B.XN;$BN
MXY3L65(0>(L'9?6:#1Z/!G88+&]D5"=)4Z+CX'M.:042HS04)6'W!N@7YPW*
MA<9XY!_=6Z"2SB\P")5)AL),1DO-#N+SF^^]V79UZZZ/1^^S[>=\I682*PLY
MI,V'8(D!K%R#LL',$'0 G@FI[+!#2;S,T%N#'D**]VW!>&82 >-'^5<3+YS@
MA,2R04O:6P==K3(1@X#L=GR.N;-^E]7D[ @3!3KI0#X#B,AF1_Z:(=,RP6+X
M)WXHPK>TB06P#B '5I[@-[2,2.@9WP+Z)0@=$HXH(R*.(++TN6CS6)X3 H#%
MMB#C$X_)4?I%7!3 W867=>@=HZ6\>[@1>&PH]U5=REB41,*/T_;(T/INR(K-
M F$/GJB3)6WU8WS9&1N&3]0OF(T(7W^J.-GF*__=$35_&\P&/%'GJR6L<UK%
MLRQYHH[CA>9-.BYQZ0^"Z)=Y"K_Y\B)SGY/?RUQHTC18?29OA?F,]<F$O51I
MANI!S@RM,']%R AB,M"2N*T[>8KX\3S.<I$[H5<'AK)9$J"K+Y;LH:S*!=@V
MOM\UQKPU"?W)U5+?;L63K0>3@7#*-"$!LO?CPX=DTE+2!#S<R1E/FB#=%6Q4
M/9_CX**].?]4F-WI0HN2:]+5ET0,B%#P^#-IDS7S=YXU3I4,-[)\+;MF&2O)
M?/*U&V<\\AA]%#R'/Q9.S\)ZZQ;/(TZ<XH"LD\' UKO(SB0TU6C>)(HB$(QL
M%I#HA9F0.\U_Y>1.</TUU^>@?WT:DQA,UE;=SF!SV2^R;*NZE9"6H=H?!YTJ
M<<U6,=XFLHOQ'T*-E E+;A90/ZY*I("5O 94N,@H&Q@"M0G_%,1"+W0.ZZFR
M.LT28]+BM'%??BVKM^J,#AU.\TU!>5#T=ZWF&@B/](ZV G(I$U(61=W;)P*8
MVT$B];RLT+N$'[Z*B\NX:7#'.8L;-5%[Y>Q[]W'@7K+YX*[B^E*-B7LPB0AO
M09F)Q6Y=#AML-Q9@_(']MC-([13(MQ&X/6QEA:0LX+LIZEM;%V$L_N*XRMC)
MVQ*K(F4-[S"RGIZ[1A(A'$^5P<+ME*!0_]6\+G8Z<Q*9G;,I![$1,+,%S-T*
MC'FSGV8-/5WI,(\]]M(T8)8W4/T=YA+&/?UP9SSJ.*?1&8W!CC?GYR?'.U[<
M8ZW;$S/YP+)#)R#Y;19<&PF;>U&6J;(IE[#!%.R,V%F'%,\BE'+^*1N=$XSO
M<\JP9T%XHM-:L$Z&?NO+T$B\:UB(!616U+>,S:+*QM^9O7@2T<_+X)5C4O)0
MCH0?N<)97/%^&(4%,W-!44Y7RGK#S<T>C\A&HYQ,NV8S+?)VX<7J^=V>J"UX
MAW&V;N!D)1XD+M6.+]48PEW&OW4EGLJN'RG0R]2'4,M8A_FC>IEZ7[4,Z @W
MDF@&^-XZ#6MP$SZ2HD478S--2WTL18ONQ?MH6FI T2+ZN<$SKVYSS(<EDIMZ
MYAW3VM0QSZ)I*WLW487.Q&>#%4+A@4=<GT&2QN4"2HH76KH)9U:[BI!N[@?Z
M<+C* \8C%09=.P4F!P)_CR_(HT<,-$*N8,J!)>??7*62"K;DPWY>%Q,G#@P3
M6L8RI:Z(IHH-DX;BI;%;9>AY#/L_Q;=Y16UI5F,*#,<"B-! \TBJ;,;RE!-9
M=K_;2B=;>Q,*#)6&" ;Y.9+]EJ>!'73&'X\.K\*RC C+1O62%9E8=1]0]'M.
ML>*+[\_IP60G*)X!VLX6"YUF<(Q BL"^0&B&L0@,GDO&O&BG(H$RKFC!ZX()
M@37I+O[P.(<B$)+T0C1!\<$UM4^BV:1MTC 1^@%6QPLRIL \<^1,*FF'L0Q&
MD0*^@(L*^,D7ED5NE*%O,7WD^.#PU?'1BZ-]TH9"K=]Q>\Z&2/6B<&3G<EPL
M+P**T$2FR&KX_AUUGGKMCFN+#MM>A,XO@Q)1L%\P?*\X7H^D-TUA36F[4--H
M@ PD?(9I&K?%XHGI2JEV"YJZ%)8V+GD#60_EWGE!R#NG-V_F4WWXU7TJ[M.'
M7]VGGY5E]PCDT/%/TY\.7X%E!R+D\/35G;B7ZY-0.M7F)&E!Q,4HOS/C.<58
M)9H4:#;$59ZQ]F3S5R2QS4]Z\[*;.7-CXK*/3(Z"32D45(OB FB,GR&%$\?D
MT+AAI5;K+V U"JUJO"XL;KS')3?7CD_JC.BGDAX!8@7TZ*V]W0G,:55+RATJ
M+/@YZC.),V+=@VCOX4[$=M%^"'%'O2CSO+PV9A &^O*PC@ V.S".^IL/:GV)
M(<B$,JOM&GB1LL6P([Y@Z2DL63U4N<YU"QB1QH7A?X.B>R_14%&>H:BN1W,V
M?+)B,-N<3Z?[<)C[9: .:M(#O<+J.6:&@SD4R7^W\ZQX*\%&/6N\O)@P\DLV
M\I4X++TW840X#!W;9'.L;'96" IC-(U71CDMER8.:SPT[MTEV"5@%%"^O5=V
M[EY$R0-A^CK=GGX6KG],$Y=\:%-%C0%$B0))LV&>ZE".[Y8X\FF"YB".3#%^
MZF4D3L+#(BJ4XJJA-UL/0N((F]R/[EPYY<JOO]'->&0U.N-2V..QUHYSEUGO
M\XE:5UP]'LF%[157>Y8GN=W"Z^B\$J%Q:;;[$?+[>%9>R>WT8$M,.5WGW#AP
M:+.M@2U7+<YT78(R77WD*H/OWXN<,TEXGYV:_:I6/T:P\R0V]O:,)X4SY@4!
M;]K3Y+<" ;%&;0_T=4G9C9C:C<I."6 WJ.QXFP*=W6+IK.?%KIP[9ED:YK_T
M#V'N64M .>23\(OC43*[&V1024S=R*9O<H40_)ZU1TQ7LG?&/#_TM?0GR%/:
MH90[CDO@H/BEJ88(\OZ!6EH=5NBM8SV2-$F*;Y?V.#D>W76\(G)G,#]9\UHJ
M3(JK@N5-><TN;V'%W15/\#>6]:VM#2PKO#.!J[&+2[)VAC =W D_W!70=7CH
MY?PN!V2-0O[=C@NKH)_AQ<GIJQM\# 93P4_D0G=72K&S"D,=FU7+P!7V%$KX
M2ZJ6R;,Z1[04JNEH'<J730HKV*$-GV7 /A"U;+@Z!DG2.N5B']/ YO3!///X
MNB^>QR.\Y28=RVHJ\O!<6]XL"^^DMDF8$8ZKD.Q3=&K[!4FA.HS.Y+OBH;B9
MW+[?4<<GZL71P9O]H^GIKQCF>\D!OI^/7C]1\+,WIT=4?(*U*"?G/Q^>JI?3
M?U$-RLNCZ?'^X1?F!1PP(;U,XDIS;#\03C-.QV]() #=TZ^0F7(19A!\6*>T
MDY 36XY%N;U)0,RU%_?B;RG-^RJKFM;>UQM<BLQ>.QQF(^0NKN=J;E@QU9C&
MH.."%I[%5=> \9XD=+JB!)E@4*[R+)YEN05S(B%"9I.Z+/-4(*9(AP/FD9$=
MT65.E0.X,KDDJK,U0RD*L(>Z,%QL$*-!:DV<[B5%% [[[#I&B($O[7X,E,A3
M#/D:@Z:L=45A?*,;U"AG-F7<#])&*HS?X-$N40]ST<24D<W0J1"B#X;A<C":
M71FEES-F?>HS!-ZLWWHPI?3<Q-C.GK+C9Y$$Y9E\+1$X,R[B-#:4F-&U0%*#
MM:!_I?ER=)L?=L:C_STZ/C\\QC^G+U_^JDY>'9V?'Q[\O[NP^,UB =]^C05(
M+.#;K[& S^IZ_KBC]E^>G!T=_T2:P'CDUU"N21[P!:(I/0Q-Q378C%VC;P!C
M%86J.( L[EZ,GN<8H=BO$=6.BIHHHEJ$D ;LDMVL-EI,7%2NAI03BMVWLSI+
M07TAD$\I:G*14:D='EZ'36PU<P^2R&QL_;;7\EI%+GIEEC"?[EXNNYJ=G8)D
M=5$JP !Z;N^=/"\PZP;+:2-3?XM;;V%-YC8D8"JEXUQL>BFAM25 0[:@K;E1
MDHGF*:+KG,-WO&X:_4HN&5#@E[!LDMV5?EH5&+P-U]PG9+-;VI/<*=&DD @B
M5U4<N9)B')#2IB14H"W&0)CP%UYGG@BIQ .3N2$C>-,24A^AV&"G*O39UE@4
M6%8FI6X\ZN?449X,XXT8*+:!?*TTN V>13)OJR*K+T6Y1.^512\A_$53M\Q,
MP#H=*!!!+LF5(.3:>1L<3<JZY.S12[U@=VA=L].-7B0;>(=50V,N=.6*0 +1
M 5BP-G96]O@\<QT+#5HNL\*(+*9#<UZ=:D9V:LTS?2/SQ@@D&[$F7!/*&&!R
M:._IM3[<K&#07T8$GDDE9D"[PT_>Y6/?9S2(8Y=$Z2*:)O-1DIH#@>3=RQI>
M0%(XDM)D&V\7083\ VY9#/88Y5[:*E1/\+*]9HIA@^ )9M>:Z(FD\($B04:J
MK1:=9^AR>:\Z]:!8/$<\/<8,!\DL+[,IIZ;.=CRB2/8<+%QDVDND/^+B>5EB
MW8RN*N#MN-0DB"#G\8)"S: JT2>$+QBD/&:(/8[T&%&=+KX%YY?',ZY^7;9<
M54/U,U1>>X$/%VR_VL1MKK*F&'8"%R?RQ#F'BSL9;C2BQ^.-5!_0 8MT#1I-
M8Y+:3+H%$P'=T%2X0J4]IQ01#643A[F9I+-*M)WQQ-#S5!87VZBT2%A^V*LD
M^$VARE1YXT?FSU1?Z;Q<2M'+59E?,:R?#[!M'N$-BH,$<UMR;?.!X?LXJVK)
M!S;E?8[(ET D?#JT*'&8_</F'S"B!W&UL%K;EG%OHI7Z1^V?,F4#_/%C5HUQ
M=I+OCZ-\QNL6&6V8A3*.&(1ADYS+!9#1(*@($$FDI.4+FP4VK_:W-KWPP?9[
M^D%=>B@2J.JD< UXS09<((.372PKO!/L&J)[C0&)FFL=4;ZS[N8X!EM'50?2
M)43[+[RHF&=I2#3C=^WP>-3;XKLL;0XF"*58DX>A<:%FT7Y9>;T%5(<AUOQ0
MJ,WZZ7,9"['@I;I8L^@QYY%5!!9A:Q%-U!I.QAV]W/5\98C +SB2 ;"[DVY\
MP<B8!FTM:%U 70O0B @7KK(0<01%6?N?5,A]..['7YK\7C<HHFV!Y"-EN/3N
MGC:"KJR,XDJ3$G*\72P*?$]O, Z'@. A^25E*Z@Q48%43QS9>B:8,NZ-[YR5
M<K)8S>+B+6T<2GKX.2R]NTX08WDL(M*4D&*@6^!>Y#6&VSO. !>L:KG&*$#:
MX!S\!29FP:_,!*B^TD'GZJ;);0PBR75<L:)H4*.%4KC =3SB"M?( XD*2U^#
M-<';3<(@S>:RA.LB@97,-)/)&A/-$?@1!#KE9YC_FFP<\H*SLL&9>:1^+,++
MX(M;(!S41DPL-GR[$8:])402C!D:4H[(!IIC4!NE]DC!)E9P<Q(BD.NX,F38
M'YR*[WIO"&]OH$O1T6#%:T?.4Q4C7];Q"':[*!=9@GAFN,J$V\H,H:"$AVJ.
M#L-^>:VO<6(&.M$3?N[:79G$.))T0@JR+K2$W^(&-U;@U8C6RGDAFTN^FV2:
MVD2D6<?0AY9I=T)B;18T>/0U:"!!@T=?@P:?ATYUB/F<8@%V^3,(!5ON6S"2
M5XO*$K>O<=6G9*Q6KNV-IVD4E R,[I5RV8A]SC#9DB(12G[+[TDQ8'E&/>\B
MX[KIJV[+RL#_:FYH6'#FT)J(!:E*+.@%5T&, /S+Y1]:=#Q<FV=8S0/LE2=F
M;[+BM[80!0713*LXX\9.QJ26?\P]:022#JTDV0BGH$@8F\$NX G*;*5T15\1
MZJMULK'#^^1OYH??,MZ4M7OFZ\9?6B+%BQ"AQ1T::!@%@R%PM?Z0N4?26'OX
MP'Y3"].:S"] -.YU]%8B2@"E)'&=-=.VR].1\!?ZQX*X6N0'U3C48^I:NYZ$
MVG397-<Z+9SRG9#T:X[YIXDZZ8-@!VT6PWS(=:&)(=\S)]L".[C4049D%$00
MV3G@ AGUT%BH3PY%,3Q(>"#%&AV #:9Y^4BP%*62*G3_\V'7N/>.?G.\;B/B
M.TP:&/8SP8Q(VD5CT%1Z%[+;(CC'!>>L(2_'JH? D+BI-UB*'QA$S=L+QDV_
M24K\9;FVDO*#6\ZS&_6X)2YWAP_7=I':W5$_G?QR>'I\=/S3>/1R^J]>0UP#
M"\,:#VE D0FE2U9I'[,BLMEN5BXW$ANQ:$L!? TB*%EQ8/,JF"0D;0!>A 1&
ML"J9A"AIU-Z4D55((FA<(^#40$FB2<-FXLK0O]+)OS8S]^H1>V^R-&P0/BAZ
MRB8EM54U6*R%GF=V1,*\T+5-I161DU4HU*Q#7CJIFHZM2ZR0: AQA-94[Z@I
MYB@2:BR^AWQ L$S0ME8]'%7!U:>(B@'-&L+2L1457DA</.D$]1!F[^,".%Y4
MFWS3H"U #XDFC'.S+[);3$!14U 36\)_LS-PB0?JO5"_X)WWY7YO'.;'^('@
MN:2N_3O3G0-]:Y<(3F%0P_:Q748'T8U[T_1=+ >85@KZ,#]K^<\9+ AF@K4U
MY@?!<.1"I'WFRLZ2'&)9Z;G0D/39C<2%0=*AB,D0]"'..K8^G/6;'/D@\#Z$
MF]P.FQ+=!<;#S]YGCPQ-#._0>#2\16IHAX*(S/JEO1>-8J\'5F <L ;K!=WT
M(!\SSBB2THZ(\./XC*18&G\KG//V"5M@[D] >\,;2W@;_D4=P,=SU5JB*BYB
MBD_/K#8&?RP$*RN(.I@LAIY*@!7Q%!413F:!KZ[T)C.(-MS?M9!_=L"NWG?K
MVCI4]1YK5/TE=J<S@/BT*>4?E]Q0N)=$.*"-48&K&?DZ9GO?R!N,% $)=X$9
MQ87JA!775.VHHWDH?XTQMU@(H,LPJZ<D)6,-KCJ ,7&(.F3:NAAL&8TMIJFX
MDMYH=(;!]W@)7K:YD+A^/?G/!:%HI#2@0Q::(F:VWM&4K]>2CF6K/&T3)*O.
M<N6YY#22+VAIP@DDZZNR]AK(KYWVG=!0-_-!?_?5!RT^Z.^^^J _+QMJ#U%L
MSH].#T$X_'1Z2& V]U\=G>WWS(6@0$>[NOKUQ7$3I1>S,LTL: L:0!Z.("4'
MH!YO8 W&(]^I-61IU"T6HND4N1:I)^CX\:ROWI $V>CKURX6RRFBMH+O:,X!
M<\NFA\%2;'=Z9_0S5B+6?!==-,3"BL9(\JNT#P%@ 3W%"XX_\6<@0Y@8/LM8
MOS!/W3#;R/B?'4[/6A]E][39967LT(5-AW I2PLX6-(<*%),2::2DT[.=:]:
MB\+D N_G#%JXIY=^8\50<Y4RBAO<I%'WV)W+=(U^X(.M)>N*\COY+.QD=WYY
MQL&UQO^@]3[3#F 3M=CKDKSYB$- ;0EUA91==^H@J2BCT^S'F71HN&1<D%X6
MVNX6=2<-+Y1YAO,6K#I&P_NO]Q->G)<AM@VWO(T@4N>=\/0)[&@$SUMCO&X0
MBY@4;#I;<WT+=%8C)>%KW*R]N1#N/G$(B9"(,<UPVRVU/AR/W&0PM21.:M#P
M<K&+O5R86.TLT[EB?RUEF<K-<Z.)^D85Q_#[/M2I!W_A>3U6%BX4VUF7U GZ
MFDH59QI&G'=?D]66#B9^C'^A!T($-28KL,_9+@U>06MQ0Z+H&X^H?TZ,J\TN
M"#:J&:Q"]BR>(5N1?=("\RM-_+#<&)A(E0H1L._'%!]'K+_?7!/$(WG^,7<O
M@T16J_$O)59!D#68@[BT\4UGNKK(#)L0O1:)7L_-%V(5QE=EQEX].,2T;&>B
M7%>F5]$\ Z)%$(2VCFWGW31L/MTI$!J/WB"M&W;6378'$^6*L;E_X"9/$7/#
M]=$:#\^:R?(61DV0+FM!=JU%#%(R0V1PN^.-(*W<!:7[%I7F 0(SG!_M'YZ1
ME]$5V#!46X#6M5BTA879=9DWR+=L873IFX3BU36TXL!B_3"@(0_+CU&Q,<;I
M!;R@\$Z4P(>%_Q%@'K>^VHH]&#SD0AZ?BRRS$/2YLK,6@A[V$S;1O(>-,&8\
MZ!$BO(4C!QRF[H$FV0#;=X\?[JKESF)';;G. P2##F<XH<Q&%Y).8Q 26S->
M!\+PP39XWPUT(/_CB[2NBN&5P1YTED933@G0*K99?.$B**L];@R"VP9[0 VS
M@EU(>!>(N7:V81X  9JM6+#]S[N@N2$7%=Q3P8/)V*-@8E)>%(SMG7&] 8(N
MBO^%D_5  +%SG]HE(PM/=+:T6::"L8A](LM%L.>9=P^8](E\6=*8K9Z;W%5S
MP5@="^Z6O1Z<ZFX0WM;0WQW*J][,0_#]5P^!> B^_^HA^+S$Z<,=#\N(&VL/
M@AFMPRY1'PNZ!-G8 '9)O0Z[1-T$78*X)=OUV]5[89:P)<X!-P^9Q.KC=X%_
MW4(=W^XH;&Y#A'%\\@8( 3U(9^]GBI!PB$P172J* 3YIN]V3M>JT=T(E-%5_
MG:B"38+JA3&J,M>=*'#CPL#=]@WF*:[(X((1SLBK#7 "$O*UGM59([#NJ"M1
M)QG*UFLR@Q^(ZKQ-8G?^]D)?U\MX:5++?@/9#4*=ZZS(%J?2K/Y=^A(HZ]'.
M>+1_<OSBZ  =E-.71^>_[@P6/&,<GEC+6ZV78F!YN'M''IK=EK20(&N)O7ES
M<A3--*A@$Q4 ]M&!6@_=ED-<\#'WPKX.G$F*A9"V%,=K!-'-W^42:Q.$VK(8
M2B\YB>#4/>FU)IA$0?J'BT,.XO!%#OE/$BD$R(LNUYIM,JU:LHFW?N3;-SWD
M8QS?!C@\?(Z]6/5XY"9_TZE2-A4L#R_)J>><P%2#VTX<-%[V4,'S& WOO6D\
M\E]E[>NV6I8.T-'#Z29O" S*25V2^[,&F%F>#JA.]&#^"C,(AA?MX&0=]M:Z
MWWI87*R&+S3>5TE(M8]0YR&@(DY").K'AH+2*]@'A=PR9=%";6AD<!JUSN'0
MJQ+T_HX!,/$R+C=KH\[12KP&X8G>BF9M^/8->)J]W5NW=?RMNP8@B,IK#'F;
MW$T=; R[<J5/&\'/HAO6JWJ/,:S+Y4#NNA#*'Q<5D\KAU_/R7O6"YJ:?],#F
M7&5E[JVZTVPLZ\W-36G]0?@EV]U7D@&-A!*0\2S&2B^6Z&SU;HO7V#:/P^M6
MW/K282*P#HG>5O4KS8<VRM6P\6;8=EDHC:CZDVKXI/9<0 W69-R8#*WN' V;
M%N#7&YEGD(Z<=;MO.W(UW6LZ[^K=[C57PO2V@O7/RKAB*QVO,.T(IQECGNQB
MF9<K^M#36K!T#1\E'PIE$ BZ94*^?'3Q2CS$!:76),</]XCP/5Y65URW9>-1
MHN.:<YIFNB>YV>]T72KL0[>"MP@QVA<8E_D LKJK.P9Y7;(3IA>@6'<KU],<
MB01?=R YKSPQ[Q&T]B>R7E /SL*@#?0)$@^ *4V$)J[$@$[?\C)A;L.7=8@U
M=&)E4=>99%<ZN!7X+%*<)"IQMK.(5V-'NF),2J[JF)*51A#4G/)H&:J#UQN0
M2H-1H"!7F)WK.KUY,^KRD[6X_[CE-3>Z<(9\/_>>_>_3HV?(D#A4D9K^>!BD
M0\^+STP%"I8<E;F> V/+X^(M;-C1LP\'7,G_C]ORYY4G_:XY;.(9_.&K9U \
M@S]\F9[!SX&ZW^/-KW,4R\QDJX63XU:88C)#)=UJ:]W4$J L6S_4.^/HOPFB
M5;I!L<4Y/"XXRUE%@GF8E,L!!))/[2DYGSY_>:CV#U^^?#T].#@Z_NF?]W;O
MT=]GKZ?[YN\_QJO[5^H)2*^TN<2Q=O\.E'M^:EY!7J@DSLV\880U"\')'YC'
M9#C+I\X/G@U]^Z!'E<CD[SW[15>K[D.#+VTJ;$^[@L.O(WH 9G'__!3?B!OY
M9TM5=YK^Z75/][UGYQV6Y<Q)F>?QL@8>9?YUCUC+S6=YS["?6_;9K(MVV#RP
M?X++.O[GO0?W;GSXZ8N3XW-_E=OS>)'EJ\>WK9-^6V?_T;PM]Y[9_AQ/[^.8
MS\()^;,D*OA,UC_T\(>9J[U(WZ]C[VNF'C[_Z._K0H\?[.2>KQX/GID5L[?H
M%VONH"S@X:._?\C)WJ_OJ[-XH5[D&G3T2WCDLZ"W3W/'2&VZ\:P^\@2^V)T_
MQS8B?^[68WHTN6E6ZG6%2,;+./_L3^"#//#'%G2K@/B AS3UTF8X8V:89KX>
MT5].OWGTXZYZ%:<91MBF5+$:J8<_@G7S(B_+ZK,XY4^_*:ZL\_A7U'D?//A"
M-V+:B#OLL?J_8+(N+]5IG.?E1]B-3\G.#C%3$?8+T3;+_];S2[+-+ZJR7>XD
MY6+3U0U;?-:.NVN&MK.I;Z%#-JA[Q[7):H#BJ-A;IW((ZG<.@RZ8*:,.81:!
MQ<6@0 IGT9N\ T)/Z<@SMN@_L$_"IZ#AZX\[9\^+?16;/#;$->P-5+==PAO/
MO//RC4[^[/QT>JR^B1<P-&;;38]_C=31\?Y.?V*_^P;]=9P;@<&\H6W\19O!
MTP*4S6MU=ADO]:<2-)_$F/V0<OFOO4<WF)T?\"W[EYG&OMI4 '>EU0EG"WRR
M_?I='W[>FM.G,01O7]%?>Q<?J)_AFP9#;@<5I1V<M9B/^]WN[E]<L_Z?-BNP
M7]NKJ=I]L/?]WE]\.9[YXW/<2/W)K.7CVD6@.Z]J7.=_8TE#\3XFT3J5[J^3
M7/+^;]XD)>+'KRD1DA+QXY>9$O&Y4+))B )SZ?#XX,TK-?W(+SHZ/CA\=7ST
MXFB?.LVKUZ<GOQR=8<_YNUL0LL\-IJC E8O<VYJ0-3 A%U,]4OAY&K8B0><$
MIL$B (R*36,CTX201Y&43H?=0?6OG.+H#YNY<N@[W"SSJ+ ]1TWW4,E?'H\(
M2\WFQC(6#6,H("C-0J>KVY/(35&610N"\W@=,T((UF@P/ $7?DF)QB0 ;W80
M?B4E:>,@#*& _;G@V*M%CLKTT(M]-&^>_] T7/G918P5?0$0(K:;PVU.\CA;
M8 YT&B^P5#GR^[M&:JF+.&<8#-,>!!$QKN,J12#B#-AX+D RA+46.: U:3-%
M^&WFN2(-)B'PGQ&AY-51OY]I ,U&)&YA5 5YN#LDUR!U$.!NFA7U:\FX[0R^
M:U%RKKWD%5."EP/$EAE@,1*1%6)\+$O8I!!,R%5FNNHFHCJ7YNQW7MEDZV1'
M"/?&8-A16V-OC_!U#%_'_X3GI;L0D*!V^> >AETD"(4>_!Z!57K[[LICV*XC
M!,QNR0I2@?S<=A'"5W4)<\6@+%0[,9FH+?2?,6A$#I:!*QDC\O3*Q"+)]<]7
M/#_S%U!N$K>U0"%[T%@1EFSHU*#!!"BU!I"SLXAH""F2&^^9.BD/S+)[P,)7
M8E-QMK(]& V:SVPUU!&TNY,$:<A@YX+UXC!0;,=F.HEB._B(D_2]ZSL>N8)A
M)Q;6(;=TI^:)#XTUSAU8- _]$>L + P%#L7(WWC&$1<4HX8&(W4K6N92'NWC
M[UA,K%5DH7:4#XKFP6'U1-X6GRNU=+4US)$%M*>VE6X@1RT&DLW#KZ<R7VHE
M8A^8F#94!@;3I'8.U,%1CU 4*G[5M@='Q@/=N*^V*;;M4M?8:@U[B_FBT!',
MRY;;)\54Y9*[ADY8UWE[+Y M K42,#EXIZU?7"YUG$_P(VG"BY5=&I$Q,Q#/
MF?3SL/?3UJ5<5-C3M- 70)%:J!:K$N9MKN!.&!AK$60>IQB/F%746K_ESGCA
M'EF4FCM<-QS4F^=UZ1>=8R'C &?U%$;"[A;IO'(,G,_(YZ"1L*"F$F[5E%43
M"+-)MUGRG%K1D,(Z5+C(?>),(['NU>@7M<T#_#^6BAN1OET?"*3Z#U*_^D#$
M+_UY:7Z] P)QLMF5^$L7X/PN4J_U#;B;IDT148%M<.)@AK@$O.XJ$_@CJU ,
M*,B>=O%XH-D=-G=FN61EFD8\_OD<B([ T=#[Q[HO-]ZE%KP$E[:N^C!H0AZ1
M@+%HCW %8?K!>O!.F79X;/W9.FK3ZLE#!R&,#X?A[B;@54FB3"[H0[\5L#=M
MMY)-IDT<H#=OTZ&*IKJ@8L^;%0B_JC*TVCPN%GD%>P[5?.48E?2(E^=ZM^].
MR(K-'(I[NU\]BN)1W-O]ZE+\+/29H[FQB0:M3M*(0[,SJRTD?1I)>VUC6 YH
M/PCV4$H!-7S'[H. Y1#"J^W/C.X6GY=(EQ97@0L#+I8-PMH]L0")'EZ"54;F
M<9;;)GP#$X/Y#+S.]8G&NEY]I4,="[6(GCGGT!G;@IQ#0QXHZN$@BA]M!5K^
M[VOR9[7?KB^#29DB;X9TEC43RK3?N6EP [RN3Q9M6M"3X$"XG2 Q?T+" L4*
MT["<U>1!TE34IIR;0LPU6=6,FT4NF4Q6;8QUB\N+LR.$)2/0"="W:P /;F8T
M_''7.4NF'L$E8<\STD)K;B/@9F ,]&M0N"]+1",,YI0U3G;/2>S>X+2"L< $
M( QF@MQ $&6&ZY6WHF3FU[JV2(AQT$-BF!IU.OA]U-&\":^Y;K1!K67MR)V!
M"HY _('<OQ$!?K.![::6R?+.5#-B8@],96>@\2$L10KAC>G@-\QF-D-NS<#Q
M.6!>4FNK[MS@]G0PAX;F0- IO;95W2<'#*!()DL8 VB+5.@>TF[2D<-GI=[6
M\YA@5"H[ICD8T+NL"\7:.GT/:61XA9"'V:E(N;<3\S7C$]H+8\$(/'@!0]A&
MU8@QH*D05H8G2Y\=J')VM [!&!9,\'6N<NX?'@R/UYEK;MF!C4Y=:\EZZS.]
M.&37#,232DLMK<O93R0\FI!"'4I5G'I>.3+"NCVZ$"BI>^N9PTGG4L;;<TC.
MWM.T"Y<QVM0H*OR;0MW1\683FAJ'')8M^[[,<?9>S(XK*SZE]W9RXS-W0M]=
M&]SA7KC<=!PE,_$"?(C=Y B\T8AO'2Y*-FL; \$;"W.8LQ<DM$E"=.R;K99,
MFN/!V"C'!GP0X]$'=D)0MR<D^NZTO.X&XIM,;8\=Q-R+QB/$>E'(L"[$3_-N
M2=E:_6Z._I9V7Q0,BN,4 UJ-W7,;/A,W)6*@W10;, VY9 N8%77[&4KT!'VW
M5[:='T*Q))K:-G1<3 8])C!XL:7=K,[2+*Y,BUIKV*/QSJM"J0K2-8UNT@_,
M;^FDW*\9F0I1@ A:D?IC,AX0UA7XU)2B1$(O7(Z!#%JT*?M'ADSFBN X!ZV<
M0JB^R!X-*<(,@<-*<Z7GZ!:A$00F9V #(R1DN#WH:PQ^(!(HZ-O[A[=H#>J9
M9:D$RY0TM1] ,6W;K _.K-@XP1&\$L.*M<05<GV%ESE@!M1V@A5J!$LR^(%\
M=7V] L1/W*:@<%+WD*P.PQ1.%R$O4,[A>)_9F/BKA2A$%#V#QXV;W'NE>Z'J
MO<\V$%E+]ELD(IH,:R0=LKOY>K+1M5 WW(IN5S+2=G']"&AK[GE\<5&!?&TZ
M6PT6](I1XBJ9$?TU,RT31!M80Q2=]I=!YTC'4<)($&T4H=[+AID)+A#;B[HE
M4*LP4@L8==QRCPV"=)QW$<P+]L.;6!^(JX_ !1H\ W#QSGK3<PR4;WJ>#VI/
MZ"078">[+NF!AAW7LK*M;UE:1^#]>3@CGU![.);>=W[CHH+!^)>YYEB8<+MN
M<UEI:]3<XK 6/A4TP)!F]E?<_.*FOD6]D<%>&?"5!EUN!V]VV+-6.M5Z375N
M:HL[0&ZL6378&]?HNF%KW,B\(U+X(]LJMQ8+,4!O^P $]CN@OGRJZWKJ;BB2
MNVVH/SS8WMX'&NCI\V=/[S\?]!*?@FC9-D[&=<[@M;L9U@EZ3_N)PI[3F$8;
M\!B;;4,GJ/R_[P0-)OEA]L.\T=N5^\]/#GZE2KZ?SU^]?/;_ 5!+ P04
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MBOZE$91,V@];"*:@OM77(E!;;P3.1V#[@XW>XOU.T*:A,4--%;186([)UV?
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M.?47W[=:#JOV<!\)6;P/<)DU /-K:4Y&! 7BN5#%#3*=$^YLQK-F4.G=2%[
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M/:"EM:=AA)P\ Q:@_5H (^,Z:TP)#@#]7K]>/D6=.(,%G%7YY ,8<? ;_2I
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M@A9=[?4V>@%B^TF83>(T93%WK>1!@3OWQ#O^\BY\ M4*2 99+$-BWPBI4AU
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M)>!-PO$Y[M\?D9 [3]!5W&@93\BK!%K^0]&R/>Y#:O,Z7Z01VF9)"<R.IX\
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M[$^Z8VK!.*%;>I:(RI6QM<=8>G;1JO"C]D10SE+0$3MP")RZ0;78:(R&S,I
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M/LW2"C3XP?PLK6C\PEH<>B6P6KZH<E=KCIK5PLZ-15K9F)8XG[Z'0]R13@*
M"2W 2 J0AM:O RX=TZLO[)!YF.87^4+;^M:O=+-.%?J\&9V[G;6$5N=P]!'K
MG(.P-B<F;HA%#U23:.O8.B55B-<T2X43HX6"]A8G83K!SH/BFK:4(^X^Z44Z
M0 YK!*<5U/EP4FGWL%BDPBZ%;F58.FT,*Q/>[7:22DZ451[IT["6[Y*>!DX4
MS\^UJ :FZKWD^%(2#-,EM7?K=M:_G,GX@F&(MCT*#7@_71Y"&AH]:J*"G0S
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M&#?,?7'ELEN:M\$MJ>8+YP10:DAAP8CVGTOZ5:>H3GD2,^[8B95.\66<MJ6
MUE!)E=7G:)DO:(O0,EUN!T-4T'ISQ(1;MR<Z+C^.K5)Q,W7KI]VRBMP:,(6:
M63%WJMLY;WX3/>?'\HW@^ZI82'OH!)%2,QY02%D\R0"89+ZJP(0?); E**@Q
MRU,MZ]UR4>CZY"/05%'0;KHKZHF+H6PZSA3T13"I7&:L:$2)3UP\EG.K. =Q
M!_J-R,5[EE/82'SQ<XWCP9)EAHU8V!!B6,5B+D0!URS&4!26=]'I*Y-"07N
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MX)-^4]C=6&%J2&"H& (;RX<?8/]4@Z@+AJ$9S5]0<(N+5AIW1]SD3';/N_'
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M9]]%95A6]/6JN1]-HX(H&VG-#W1;J 9-O>8]X+;;]=[MB&Y!7=R\*?W(>O7
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ML@Z4HIZ@)<?ET"J,RY:\O.[/X+;>,@A "?(V55<F_CC>-&7;#JF)1PD>@IT
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M>,WSKC?*_ "$ !#@FK783H3?P@^2!7%I>-YY9@(4R:(\$HY]6L"/_"R DU.
M9DQBX1@.41J0 B42J-UR](^@BU-@J=2%%<9Q>J5>2'HM#&KT99@7[EGN1P'K
M6ZR7BSB3':,O_',0!N?X E<3(GL '@#EFG6[?!Y.T%[0XL2?S^-HXH_CVJV
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MJSNB')&X@&4)P^=#EQ=D58DW"I02?E4ZO9-(T$:WUHM2H_^?IT^]=U$8!Z^
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M*M;<74,8W\J>M5M?+(RKE"G)XAHJ*6(X<IEK/M80S)%^)PMG.6OSQ1BF<M%
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MV:L5;6P]=3>']X564PC?AJRC&,]-*'!E@5JR-:\:B"SGJ[IR39/PY=8OO_R
M0(:2JZ+BQ03VIU;IM)&Q(V>XB:K*J.?]@N_2?.TF)QO4-JM;2_->NF&[+S'1
M[-0@6;JZR67PWQEE0U*Q9L@99_+G=0SCFF:A+E]V"YC=5[9;M>^,$FHY1E$[
M27ADVO\=TGNK*<_'=@W2+S>*+\*X*3JW@DI\X^DB RM:4$P25=/K+:^?6)LC
M*MRJ/='1B'%H 6J85LT_[>1%X%;*JM0PJZ%-^:#PB5K6'-:RC>#[(EM(#Y<(
MTP%GW-6> JP2]S#)(*I.'7X4P98@H\8 7'%-K)SWQ^W'X)"/,@.SC';3G5%'
M3 RETW%\I"N,28690T4CBDGCY!'T0ODYZ'"@W1@@45817^Q<8W@P9YDA6ALK
M0IR6LY@+4< T"]$5A46P=/OR*%/Y:T!MT UB;G5K'UA.H-.C\MY8T"(UAD]Y
MF^B <9V[ =0U2 AW6J[WB)SC][(4+.%61O@+<GF;:&684=5Y7R<_Y2ZNU6,&
M:WO@B_)-K$,4S/V(<F@#MI5.YW%47WC94SVQJ;P8N%L<5HQ72RART\$YP7=P
MI)H;3(9)X(0FB&VAX8P> Z/T(9NR_IY3#RTM,E%A=*5Q9KD>)>\VU7^R$NTM
M=54E(T?6FTLMZ3K$Q 7 _C*- B6]@W0Q+GI6\$;YP,5":-*JPG*>4[W USF0
M7<'T =N?J9>OH]N"*"'7*F: 9155IB=0/I-T-L;6\$X="59G2)]X5/A!E^.]
MR_%<=&\P>#[#2N^ZT:DYW&67Z9%S<_A)C)WFJ8Y=_"+F[46E4Z!+Y(D_CS!#
MB"=:-D+(?G+\*.PQ<'(J30J=DW[I.WFG%FX^+ K!Y%,+%6@MI;'#,0DRB5#?
M6F37FBRJ5J=)L90*,,Y;1<65'3PFP8[\BTE*_I<;SVRY.FL&->X[_4HRA:CZ
M;;W(CDG[ ]6#E2892[5/XX:Y2IEO!*FJ1%CXS1R8 664=:& -5PK4Y?R)-WD
M%DO=0T!>/4?";S(*;I4R' DB1"<R2@D8J-;5:V7KY+7=>]G!9O%(AR%26\,;
MS*K=,@_0S"H83<)3V-/#S,!7O#<+G[I7<B/<[Q7W_<=-SH_D_/SX'>?\;*[+
MK2YJ;.G"BW%.1ZE0V"/>$;!/S-O-&TO.C4BIAQ$A24+1#9;NEOIL:X#GXOL3
M?2BE3B!QSI&3IC Z,6F>J%W:DG.@X4H[%&WWK&C=8O(7E 6-K2-]Y1H40::$
M%'LGVRV2!,NTFL)X3U5C,8^I6%,K;<.DE"IT_(DDE>OB(/;(F 0C\AAQLHX[
M4*^D*I2^KA8+34S-J@P;**A9>0++5\GA5J= 5<OF^"U&_Z&0-B@!S8I01V50
MX)RS0!TKV\=BZU'L6++=ZK7EA&NX[[IUBJ7VJZ>JD-A7!P(!3,%*2W0=^3D[
M\HT_,Z.J5D[[J=V=E, 7T.E*WY=>W#.CVU[]^C/9%!53A18F&*Q:'[DSUM/U
M&F;K=91'N>=)R4=M EU-3IFI'E6P>X@#*+G8-6-)PA&L!PP/I:+)^6._M(HT
MK@KW5BZ8L4VM6T;WQYJ;KH\I3<M .])R.X1 H2=@4E44!9LCE;Y:7)G8PFA+
M0W5-_^[E4])6!%U1I/ XO*;#J+9<Z&"!,"+KI6/(6XKP?I@ ))LFI3"\(YS+
M\J6[\ITT,'C@BYH8/> X2^%<HDC<M[U/K +L+ZB.1Q^E"F2FZP'KE:'+^<@&
MZ.S(!+=;^JM4/&..[4=L%5U>((:Q?5K'D?TBO:P'*%JQDF'V'&=/L<@2VYGB
MN.BLK#\&XJA+^W.L51L<& MEN]H"-DLTJDG/J"3X[9QEGYF>KPD$"LT<P^[3
M:0]KT%P;M6=A,8.^CWMR3O&/'N5_<76=];$U%:G!LA!NNA;\BWT6C$;#^AQP
M5#H*VAO@XL7;<6_DT":G1S+AFE"FG<KE&H9MSTD'&+%6K$%$V2 =UOLD"0;;
MOJZO_%3YO-9]!+#RZRD_7K/N4Q_[7:'\3)<J/Q72KZ79@$9R.ZJ-5Z/9F,V4
MP';U>!A]IMTR"@W5K_Y]M<:SM1IGN'5T&CZOMZ/4K'E%*AJ-ZDO0I-DL\>77
M*39+ANN:,+W)_*O\R,HI:51J>*ZE1AXK=1SO)BH.)G=N=)QO8U%KN 9_VK@&
MQ37XT\8U^)U?EUML,J9-@G>+)/!G!$) K064@L@V@?6M9WV)P?,;!LQ[W/_"
MCETR.$5\S4E#ZF\]<BA@YBF:$)Q/RYG4EOJ:2WPHYRKPD"+!G-U-UUF'I6P#
MA7*1:"S2QNRZNYYNP&$A'BB !#%/T(D:@6*5<;T#*4TD* F:IMNX'F>JZ)CI
M>7%(BG$<31 J!,68PJ_H:82('E<+D7RD)N_:<M+M*E&($_0?!KN0T 57!5F3
M%IO*4-0'PR23=-8ZPJKPN;5#]GJX;EX0W*8TS4)!MT]Y#T*5KLZ?=%2I0C7_
MV=T#ZJ&B-&L7?HN52DN39&VEW3(*I+2U8G4)/<QF8M:48+A(08.1TE&UU0CX
M*+7<R'@,=%,:[CIM\AQD3F3#_KC]@SZS<O3LN+-KG5*.P#K7P;O!;5!-6\J&
M(Q@7I=;C\ R;POJSND8FG':">[*(\U1%\PTYJWMDWJ$V)\I-+)?@$55M'EU#
M:W."-3>$4RS6I-YZS 39QF(VX^(A8\CS:O5YI\XDKF4]7N288Y([ >::*L(R
M))Z[(;W*=K CX"DZ BSN5FOF=U6ECGV7\&FN2H&'56GQ%>K'XVO)?:Q_7-PM
M.1.+'!QTK*O'N2E:8M*%N*5*DY&!>(4FW;<\&[<H>N9_(BR;C PAS+FD0P"'
M/)U$M)WX-Y5B;U5[K'R-$.,+M[SK=<CIH5TJ#7+3C1=)((B1?G2$;DEE?<52
MK,/AIVP+J\^1BZ?<"&AJ>3=<<%7;G>"D^:=8/96%-D16P[)UZXXZ8-D:5PFS
ML=C)9W?2E=-Z;#W/I)6MEQ7$\S#)NWB*Z *4 (U8_I;K/U#"JNYW^2*[Y*1X
MZV>FQE_%5OV8>$T4A(*49 <7^S$8$)@L!&-8S^A6D;RWO%%U%GH#]3G5R\Y+
M7H,T!IAW206?6Y2A#\?2R:QTC-UXL[?:K7)UFW;<N B(E:2E9;ER_AP%3A:5
MDK=488%>J-XUS.*SM]9I%F:06QMVV:27N5!T*+N8*54S$9=?NJ8*29B^>&EJ
ME@_S%+](XSP3.GG8%XZF*Z4(4K*GO"I<=PH,YA*-=ZXW(R\ZZH3(Y5"I@+4E
MIMM.PX"4J%M1_2S7(6;V2[7814IKT'7T936"[K%6[-CGJ+OVT<(:.5B]JVZL
MAM?NZ<H<&I9%=>@R=JX%0;-#V73U6[;IS1UYY4H(HR/?XC6Y"!O7[&G(;?L,
M22&\X7FHC%E,[%2/,: Q-/?"BX-M64.[9% L%7(BVX#8)<M-N@4[G&B=7@2E
MS$=@)H[&*L616LCG1) I(0A2F):,JDEHCONUP>I/3>M2JU:)N,9EI:I:<[U%
M8EV= "[)=;>9<3H&N4F17"I.F_I>,6 +J^WL;;6(Z:N;HL%DRMO8;BDL:DD=
M5L2+J$Z)5"37"%5!IXA""V6*JK14 _X8$2Z/4\!.>>E<F(28!^Q8KQ-=E1QI
MHF1Y#>P5)YQN8D%\";IV_KSB&ZOC0%QYK03RBIS@]:)!2Z7<FJ>$50Z%RJ[?
MQGCL$OIAR 9W.'[ Z<Q=RGQP:=Q!()J"]6GVIW 3;6FCYG!_K6?54[72J[B)
M'REQIE^Z;(9*LU]]7'1&1HD8#!*BXU"L7N#/X887EJ@+0:-+9]'$7JR=MMVH
M0&NKTXZ8-"Q>^E3K:]+$D9INF]UV8\O4A[LZO%:;EDG!ZK5B,4/"A10DGNHX
MY E$!8&N(AT[>2HM%:99RG.T>B5+?'+U!&IXO.GJ">I%9A6CBU32V 'T-U4M
M2D\3!PO]0/VBO#RA/%8ZZ@,2$CHI&UWXY3R]"LL&@I72+G+/"#N[^0/I1BN$
MG19O' $7%+8<39!Z3H?Q;3+M$'4W4$ ':@0.B6\"6P]@419XWYZ!%>*,G7:K
M3^J=^=@^.UKM*2%H:U!UY(8%A:T4%H7Z;.?9SO8V^LHU&GT=5H8+*B+'V!YX
M32O< ;^1*C(J_;$[\[)9)\HVL0JG  C1EY4>>2ME2O7SV%R9>XT%_VL3"Y98
M\+\VL>#O_+K<VJ*F7:M+BL8W84WQ[NK>=Q[C)M[?HBRP=0-;0!OI^O<XJO_Q
M(DS"2]&[2PY $.#:U^GV;+PVBG?5MU('(H589/,"^W75NR3&V*!R0GX"BL]A
M86N,W2,82J4*A57V59KB7:O\5;G<V3E.RH-+$5<I*?>S0*7=&=CWQAEVHZ*>
M=ZK? [X#32X%N*C]<F:LS;UY (NRNQ18W*^/OE9SW."@6OP0_=$E3+I2[KM)
MZ-;P.=6T=W:OPIG"BX$VNXYT./%S1J1;-A8U5?,Q;33)T(O'P2L,FIN\^X13
M/[(PP-Y^#?'^'H'8589JM_Q%<9%F0#;ZDFJ-Q,2F(*3QS5<R""2/'X-)4K/'
M7IXQ-M4:LX<OS:QX:S/T@8XA2+U>ICP6F=1@=?:EH2>Y8/U8>S3LRO22K5WM
M%.CTY30@F.6<"MMJMR$0*5W"R4'*5 "_G"/!B,,N*K*=8T3Y,#Z'JGLZ><AI
M:X3H!.ME /56)W-(>D!U$RDMQ\W:*"=IM%OU61J#NJ/K'J?+-%XDA6 W18GY
M*UP6H*.DH<<1[(\AZ57$=B$G.-"N3Z=^E%6\*>6R!%.14!<D45GH N#5(*%*
M7G]NHP:GHS /&RM4B[4@R#!K@#*6320.+&Y3#JIDT4EXCO!9U9 S]E\,<:#G
MVVCWP]6&GP<(0N,X%NV"4LG"QWFX@ GL!!(9RGT9J1>L%K_HF<8&N)^[EG^N
MMGB286N=$DK+78IR$50 7>(2./4%AB7U:K@%G2*TR:WA*/QDAEQ27%G+F51>
M$N6_T3OY97:ZO8-5X<XX7S7E^G(&O S7#B';+0O;L:[6Q^(B*@FH)_F#A@%D
MY5M,(90Y@Z?2+$IH&I@DB2UV--))3?5&5+BO08_M,BYO2%E;WU.??5?S(NZA
M7I?[5:KLEAMJ(B^W2\37A*-; EVT.HWJ%J,6\)^P5T;"PQ]0U1&Q-,D]D)Y6
M!=?Z6+4>_E3]!D,(P/YU& X!#57)EP1!2@#?^N::5G T'X7M[;;$@ G*=/7Z
M%+B=XCT$/$@^>[Y\ H.'+![SXS*0+]01X*G XD8$-.C+W#"ZI>(B3J*G%5AT
MLF@KC!CX)ZCM?A*FBQP$&:+WVNNR.F4;)%_74/'V**2!;!03'9!G45.XGY_^
MOYIVOP*GXYY7T?L<P@1<'DG,C="&<7-FH.E/**<LJ08QA-2J!LEEOT(.Z:P'
M;.0\-%:$_#+4B/SH<74[?WY&(/H<C2N#UG]'?OU'9&[<.];@2Q=K<&0T.770
M-EB##V11%M:@VD9_',7 O24Z<VQQI7?#PY.^=[( ;O;CSLYV)^QV=KK 2*7G
MKL-I$N&8)=>$W5EX-?H8R+W R+B,BB.YS "UO+ETO8"1+J[GR%DFF#A+'%^'
M5!B/7ZRH"_@!933G%\A4680"&XTN*=*/;9HHCC3!\:WD:L_*.&67#*5DNQQ1
MA]!+U0UN#A<EGJ ;BK.$.3N$>3$^O//S-NO"=L#=I$UQQ)T8=LB^(.33?FQ4
MD50@<6K3VMTD2,X-X!WI67S:5"%P)*YFVY]WMU (_FDC)YMV1QA_0P1?"7;;
M.3I2C2(:ITG5('U3'T#IJ\#MDEG]0 NRI_0DZ:Y:35,0-0<,B00+3=%^G&H8
M.D>:H[F#(+OG"3<X..>Z%;=QA,FN,KU9*X?5L5GY5*C\JQMT<)4IT3Q(VRB*
M-$M"CL!/%XC]Z79FI8:JI6:L%F(F4HKW126,BT!7STL"!:>?:(KZ:"I$4ZVA
M]?@!Z1);I^O(>FB>2J<$^PLXD-X56(Z"3Z_K!"PW.I1L>/ISSEUKM0W84SC]
MK(8*A*)"(;7^GM=HDR:]B_TO5J&2R6]@V!EE?-(C:6DEGJ2/:16JH44(ZL-Y
MZAE.Q59*%091.9>YD1#<Z3A&+,3#M,#S9P+'R35V,CA7J-(F]08V,[NNR:F7
MZFM;SYY?7.?1A+/:U';C ;'F[2)]P^V/T=BW7HX51&I57CF3<;K K#Z=;]D
MFV".FDN0TMC2NZ&XR.!<=%YT[0X.FM>YUKPUE)Q#](3;5Y<N96D@_EHU0-"@
MKFI!J&S;U0O1U*!Q:TJX:9RJ,U%/ 8N;UEZ4=(@'ZL+T^A9'@ZI&,Q01B:FR
M[BY\RLQW#R0S[XVF=:\1_9\W$7V)Z/^\B>A_Y]?E+H ?X4>:+^O.KI;L4?T;
M(G8&D;^'8+,EAYC];EH#(1U2.N#Y5CL(E9#NXSG,_2BH5QZQAV>#EJB<SJ2
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M$1KQG\)BXC1RI0Q\/#7S>1I1JVQLT:V\785.Y2 C0_,%U@KF4::/OA;:)@>
MX!%]?"<[&KBGJDD6\+U=A0JX[ZNNG%P/Q@-)6(!SY%/)'.9!*I%N225-@,P*
M5 -G;H^P.<GW&K7^91.UEJCU+YNH]7=^7>["S=Q7!6*!2N6YPT+T]9:[\V!V
M\'X6-)(NUC5*?J]:.N%HTY6V4@4KD.A)S\",I2@9!>SUL6 M-I%0M(O1AKA?
M.MFS@@6#V7SLWM2:@=O1J&*2Z^H\VXPEQX+*/!,+OXK;M$7&DHDJ+C)R7)1L
MH$B"ZG5=E51UHB[*H<PZ18E"K(1<TBTRQ'A.*0\"9I:=2Q:'=&Q><%D1#J7S
M*T*$C<)BRW46[:3;-2_:L?=H)PMJ!(:5Q%*GI1$0%;);KM0@,R/!BU28Q771
M%)5L(5@]EN=:E#25 .C$5PAOV0JEQ/X5(Z*?+Y158147LPHXLX%*53[E!S_[
M%(H-6T8_E],H,XPQ]A(T6,+B2/=-DH5:GYM28J7_K[,S.L2FPML.GACFFSJ5
M!+IP]B;O(>PS=C"9_E'E@%M#AB<FB&!2M[G5/2Y_PYHFE<"#IQW#95$@<;@$
MRYESAH>D\#,FN3*:'!VTS\BDP"),.+#(UR#W)A@]K\;Y7:A=Q0Q"%9IKM^Q&
M;YPD[O[$R0!B,#W&@ 9RS;!P3]6QF:0:&N&.N@JMR?L?DD)R7TL:D.-7,)2=
M4DK@,U<^(09S>:3<#<PIL</A=0G_9"Y>6Q:HU?&M5]OR#4$0&?<4V7S)50*_
M-6#C;,QFZ>)<(1:X+08LT "-"=!0'^M4WCL]9;EHQFFZ;- M3.F^QB*]3*.
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MXC 9JU37U*7$OY+56BO=7-$'L*A/5OV=ZBJ<LZG8)]!6L10MJ#P;EL;U#=1
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M"4.,D 5X89G &ER!AH]JF,>SM_+W4.Y=.^7O[(TU_;]TN^*=5EEZ*"Y1KX]
MA%JVA+Q-=+O5'<?QVP__K!F)Y+O!%MBR7X3ZP.[0 CODA^(5K0VM@ZH7:Z<
M!;=BT/L>/)%-4["P$&W;F+%Y2G_+(2L!? EYP.$69H=.R=MN;(P. 81)PB;I
M5UM(DU!-]AKZO/?(AAJ?DQZCZG8AF^QH$CP^?7,RM"5JZ+WCTYV<'N^H.3Y/
MZVE@@491[+^*(ZYZX$<X9NSLS,0I!L"&JH;12,<5#MPZ5]8F!;,.%J71DH8
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MX0GX4L9QHE\&=:H)CY19B&"#K0:.Z1J6)AD5J6\$VZH(C3/:+<GH8E32]8M
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M+81!S1TEN#&QD:8O$)VR &__P+LRT0^@+5#=QAB4W5%B&S.[%F2-Q&Y&_.K
M<HAM@?!6RJ#RCK+9F-HMVDX#W0FR(/$JVFH#@"(M\*&,.6B'HW0V9CAE/A<;
MGKG?/>*A/FMW(QZ47@)*"[; FFK^H$&.<MZ8YS (!)8R^<_T:U!FBP7> C,@
MUN #,$?Y+\3N]#@+3EMIP6FY!8[R7XC=V7$6G+72@K-R"QQEP3EV([UY)6[Y
M(_#T'0"W1_X#SJ#X3E/@A%O4FRMQ+?@#B5]*JG+@H$1[;+ 1![UPFB:GXR2>
M+M0Y"V)D>[3/$@8U=YHF)\2NN52(_DTV5;-3&[X]^A=I@RXXRIJ3$6%NHT#+
MKG*01FM=9 K*ZR@U-M><H< ('M991+/%/20*:NLHS_W,S5.=%6>E]Y /48W6
MV$H6U-E5NFI>"Y1@>-@?;K2R>9:0I,]^O>)(2;\+HC0?L\ \9,D=).#)GQ7:
M:*EAQJ#LCE+.&:?$UPJQY1?=#T$0M6M>Q#5:<( NJ+:C[/):8#,&L)[D1XOA
MS+O%XFJQ@"(UC&^T^A6T01<<I9D']*92AE@<ZT6A5)L<L9,'?7&4<LZP'^I
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M .>&%=H"^6V,0=F=/B1-EI7OKUSQ9T7+U+>7:($))<1!+YP^/)TRA07R%7G
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M)P+4[ZOP0/U_:H3^?L(-<.#FT4T&+!NX"3M%@#X\;YP/)=I(5M@4GLG$TE
M$TI@H/PO&B&_ARJJ\#<B@<J^A8(3J@:I?L 32?,!TS'AFX@&]KNJ&]D[H5?
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MCBAJCQ>$\U>IMB'KX+!S (2JW805P)4<4=2^65 UL^/=;TH^F7F^AS:DNJ<
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M\L$>S8^X'^XO*]AO_@%02P$"% ,4    " "Y,8U3"T.J[P8?  !*V   &P
M            @ $     96$Q-3(Q-#<M.&M?<W1R86YA;F1C;VTN:'1M4$L!
M A0#%     @ N3&-4V4QC>PHJP  T)D# !T              ( !/Q\  &5A
M,34R,30W97@Q,"TQ7W-T<F%N86YD8V\N:'1M4$L! A0#%     @ N3&-4W5/
M(>_],P  ]?P  !T              ( !HLH  &5A,34R,30W97@Q,"TR7W-T
M<F%N86YD8V\N:'1M4$L! A0#%     @ N3&-4]03YIEO50  V@ " !T
M         ( !VOX  &5A,34R,30W97@Q,"TS7W-T<F%N86YD8V\N:'1M4$L!
M A0#%     @ N3&-4P: BSV^20  )GD! !T              ( !A%0! &5A
M,34R,30W97@Q,"TT7W-T<F%N86YD8V\N:'1M4$L! A0#%     @ N3&-4\,]
M,0(-1P  \Z8! !T              ( !?9X! &5A,34R,30W97@Q,"TU7W-T
M<F%N86YD8V\N:'1M4$L! A0#%     @ N3&-4SMIEG0(#   =#8  !T
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M '-T<FXM,C R,3$R,#A?9&5F+GAM;%!+ 0(4 Q0    ( +DQC5-DT\GP+@P
M ".1   5              "  50+ @!S=')N+3(P,C$Q,C X7VQA8BYX;6Q0
M2P$"% ,4    " "Y,8U36UN+AUX(  "K8P  %0              @ &U%P(
K<W1R;BTR,#(Q,3(P.%]P<F4N>&UL4$L%!@     ,  P 7@,  $8@ @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
